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ABSTRACT 
This study examined the factors affecting treatment 
decision making for young women with early stage breast 
cancer. Thirty women, aged 35 to 52 years, were presented 
information about two equally effective chemotherapy 
treatments following surgery for breast cancer using an 
educational instrument called a "decision board." Although 
equally effective, the treatments differ with regards to 
side effects and treatment schedule. The purpose of this 
research was to investigate what factors affect the 
decision-making process. Following administration of the 
decision board, women were given a take-home version to 
review and asked to return one to two weeks later with a 
decision, at which time they completed a questionnaire. The 
theoretical framework for this study was constructed from 
the literature on self-directed learning and critical 
thinking. 
Overall, the factors rated most important to the 
treatment decision were related to quality of life, side 
effects, and length of treatment. Five factors were found 
to be rated significantly different by the women who chose 
one treatment versus the other in terms of importance to 
their decision. These were side effects in general, 
vomiting, hair loss, family role, and the number of trips to 
the cancer centre required for treatment. 
ii 
Implications and recommendations for patient education, 
research, and practice evolved from the findings of this 
study. 
, 
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CHAPTER ONE: THE PROBLEM 
Introduction 
Traditionally, patients have relied on their physicians 
for advice regarding treatment of illness and disease. 
However, in recent years a strong concern has been raised by 
society to ensure that patients, as health care consumers, 
are fully informed about their prescribed care. In 
addition, in many areas, research has enabled us to discover 
new and improved treatments that offer better survival 
outcomes. In some cases, this has allowed health care 
professionals to offer more than one treatment option to 
their clients from which their clients can choose. As a 
result, patient education and informed decision making have 
become important components in the provision of health care. 
In the field of oncology, specifically breast cancer, this 
is particularly true. 
Breast cancer affects one in nine women in Canada 
(Canadian Cancer Statistics, 1993). This means, if every 
woman lived to ninety years of age, one woman out of every 
nine is expected to develop breast cancer at some point 
during her lifetime and one woman in twenty-three will 
likely die of this disease. It is the leading cancer 
affecting women and is probably the cancer most feared by 
women. Breast cancer is the leading cause of death among 
women 35 to 55 years of age. It is more prevalent in North 
America than throughout the world. 
This study involved thirty premenopausal women newly 
diagnosed with Stage II breast cancer seen at the Hamilton 
Regional Cancer Centre for chemotherapy treatment following 
surgery_ It examined the process of patient participation 
in treatment decision making. 
Background 
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Breast cancer, upon diagnosis, is classified as Stage 
I, II, III, or IV, a measurement of the extent of the 
disease (Scanlon, 1991). Stages I and II are considered 
early breast cancers and are treatable with a definite 
chance of cure. Stage I refers to the presence of cancer in 
the breast only. Stage II refers to the detection of cancer 
in the breast and in the lymph nodes (glands) in the axilla 
(underarm area) on the same side of the body. Presently the 
standard treatment for premenopausal women with Stage II 
breast cancer is chemotherapy following initial surgery 
(Harris, Lippman, Veronesi & Willett, 1992). 
There are a number of alternative options for the 
treatment of breast cancer with chemotherapy. Recently a 
randomized clinical trial revealed that two different 
regimens of chemotherapy are equally effective in treating 
premenopausal women with Stage II breast cancer (Fisher, 
Brown, Dimitrov, Poisson, Redmond, Margolese, Bowman, 
Wolmark, Wickerham, Kardinal, Shibata, Paterson, Sutherland, 
Robert, Ager, Levy, Wolter, Wozniak, Fisher, & Deutsch, 
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1990). For this study patient accrual was conducted from 
1984 to 1988 acquiring over two thousand women throughout 
Canada and the United States. The chemotherapy regimens are 
adriamycin (doxorubicin) and cyclophosphamide (AC), and 
cyclophosphamide, methotrexate and fluorouracil (CMF). The 
two regimens of chemotherapy differ from each other with 
regards to side effects, treatment schedule, duration of 
overall treatment, and the number of required clinic visits. 
However, AC and CMF have been shown to provide the same 
survival outcome, at six years, with this patient population 
(NSABP Report, 1993). This information now allows nurses 
and physicians to present premenopausal women, with Stage II 
breast cancer, a choice of chemotherapy. Following the 
chosen treatment regimen, the patients receive the same 
follow-up care. 
The AC regimen is comprised of four cycles of 
treatment, each one 21 days apart. One cycle of AC involves 
receiving two drugs consecutively through an intravenous 
line in the arm. The administration of these two drugs 
takes approximately 60 minutes. The AC regimen requires 
four visits for treatment and is usually completed within 63 
days. Occasionally treatment is delayed due to low blood 
counts, other side effects, or an acute illness. If a woman 
experiences any of these, treatment may be delayed a week to 
allow her body to recover. To give treatment under these 
circumstances could worsen the patient's condition. 
~ 
I 
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The CMF regimen involves six cycles of treatment that 
is repeated every 28 days. One cycle of CMF involves two 
clinic visits. On Day One a patient receives two drugs, 
methotrexate and fluorouracil, consecutively through an 
intravenous line in the arm. This is repeated one week 
later on Day Eight. The administration of these two drugs 
takes approximately 20 minutes each time. The third drug, 
cyclophosphamide, is in tablet form. A woman takes the 
prescribed number of tablets every morning for 14 days, 
starting on Day Two of each cycle. The CMF regimen requires 
twelve clinic visits and is usually completed within 140 
days or six months. Again, occasionally a treatment is 
delayed a week due to low blood counts, other side effects 
or an acute illness. 
Since August 1993, the staff of the Hamilton Regional 
Cancer Centre have been offering premenopausal women newly 
diagnosed with Stage II breast cancer this choice. The 
Hamilton centre is the only centre in Ontario, and in 
Canada, offering this treatment decision opportunity. (The 
other centres in Ontario are Thunder Bay, Sudbury, Windsor, 
London, Toronto, Kingston, and Ottawa.) The other seven 
centres have continued to offer CMF, as CMF is regarded as 
the "standard" treatment. The physicians at the Hamilton 
Regional Cancer Centre felt that given the information about 
the differences between AC and CMF, women should have the 
opportunity to make their own decisions regarding their 
treatment. The choice a woman makes would likely be based 
upon her personal circumstances, values and beliefs. 
In recent years, a teaching tool has been developed at 
the Hamilton centre to assist patients in choosing between 
treatment options. This teaching tool, called a "decision 
board," acts as a visual aid with written information 
(Levine, Gafni, Markham, & MacFarlane, 1992). Presently, 
the Hamilton centre is the only institution using such an 
instrument; however, several inquiries have been made by 
other centres. Two decision boards have been designed and 
are presently in use at the centre. The first board 
presented "chemotherapy versus no chemotherapy" to Stage I 
breast cancer patients (Levine et al., 1992) and the second 
board presented "radiation therapy versus no radiation 
therapy" to Stage I.breast cancer patients (Whelan, 1993). 
I have developed a decision board to clearly explain the 
differences between AC and CMF to patients to assist them 
with their decision. This is the first time a decision 
board has been used in the setting of Stage II breast 
cancer. Also, the two previous decision boards have 
displayed a "treatment versus no treatment" choice. In 
this study the choice was between two different treatment 
durations and their associated differing toxicities. 
5 
Problem Statement 
It was the intent of this research study to develop an 
understanding of the decision-making experience for 
premenopausal women newly diagnosed with Stage II breast 
cancer when choosing between two chemotherapy regimens. 
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The purpose of this study, the primary objective, was 
to examine the factors affecting this decision-making 
process. The secondary objectives included: i) measuring 
the learning that occurs following presentation of the 
information, and ii) investigating the quality of life of 
these women at the time of the decision. These additional 
data about each subject's learning and quality of life, were 
intended to help the researcher discover further 
contributing factors to the decision-making process. 
The main research question asked was: 
What factors affected the decision-making process 
for women newly diagnosed with Stage II breast 
cancer when choosing between two equally effective 
chemotherapy regimens? 
The following sub-questions were also asked: 
i) What and how much learning occurred when the decision 
board was used to convey the information about each 
regimen? 
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ii) Were there significant differences in the "quality of 
life" experienced by the women who chose one 
chemotherapy regimen or the other? 
iii) Were there significant demographic differences between 
the women who chose one chemotherapy regimen or the 
other? 
iv) Was there a significant difference between the number 
of women who chose one chemotherapy regimen or the 
other? 
Rationale 
The concept of giving patients a choice between two 
chemotherapy regimens to treat a cancer is relatively under-
researched in oncology. Research has proven that the 
survival outcome of the two treatments is the same at six 
years (NSABP Report, 1993). As a health care provider, it 
was important to investigate why women, when presented the 
facts, chose one course of treatment over another. 
What factors were most important to women with breast 
cancer at the time of the treatment choice? Was it the side 
effects? Was it their personal situation at home? Was it 
the distance they had to travel for treatment? Was it their 
work schedule or finances? Was it their previous experience 
with another cancer patient? Did the method of 
presentation, the decision board, affect their decision? 
Was the decision a difficult one to make? Were they pleased 
to be involved in choosing their treatment or did the 
decision cause more anxiety? 
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It was anticipated that the answers to these questions 
would tell us what issues were of foremost concern for this 
population. This included whether this opportunity for 
patient involvement in treatment decision making was 
worthwhile, or whether there is something that can be 
changed to make treatment easier for women to cope with such 
as improved symptom control or psychosocial support. The 
results may indicate that one regimen was strongly preferred 
over the other. Knowing the reasons behind these patients' 
decisions may help the health care team at the Hamilton 
Regional Cancer Centre to better understand the physical, 
psychosocial and informational needs of young women with 
early stage breast cancer. It was hoped that these results 
would help lead to the formulation of recommendations for 
the future implementation of strategies and interventions. 
Theoretical Framework 
The theoretical framework for this thesis lies within 
the realm of adult education. The link to adult education 
is evident in two ways. First, there has been a general 
shift occurring within the health care system towards 
increased patient awareness and self-managed care. Second 
and more importantly, within the area of oncology and 
particularly breast cancer, a greater emphasis has been 
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placed on quality of life issues as defined by the 
individual patient. As a result, adult education has an 
important role to play to increase patient understanding and 
participation in their own care. The work of Malcolm 
Knowles, Philip Candy, and Stephen Brookfield were used to 
support this research. 
Following Knowles' work, many adult learning principles 
were practised during this study. The patients came by 
choice to the centre to seek out more information and a 
specialist's opinion regarding treatment. They were 
motivated to learn about treatment alternatives to increase 
their chance of survival or improve their quality of life. 
They were treated with respect for their opinions and 
previous knowledge and experience. Each individual was 
allowed to choose the treatment she saw as best for herself, 
given her uniqueness and individual needs. The presentation 
of the decision board was geared to the pace of the learner 
and time was allowed for questions and comments. These 
learning principles are the basis for Knowles' model of 
andragogy. The term andragogy refers to "the art and 
science of helping adults learn" (Knowles, 1990, p. 54). 
Philip Candy (1991) described self-directed learning as 
both a process (method of learning) and a product (learner 
characteristic). This means it is not simply a single 
phenomenon. He saw self-directed learning as having four 
dimensions: personal autonomy, self-management, learner-
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control, and autodidaxy. Personal autonomy refers to self-
direction as a personal quality or attribute. Self-
management refers to the ability to conduct one's own 
learning and education. Learner-control refers to the 
learner, within a formal educational setting, being 
responsible for the content, method, pace, sequence, and 
evaluation of the learning outcome, for example. Autodidaxy 
refers to the individual pursuit of learning opportunities 
other than in an institution. The focus throughout this 
thesis was on two of these dimensions, personal autonomy and 
autodidaxy. 
Stephen Brookfield (1987) has written about critical 
thinking and decision making. He described components of 
the critical thinking process, characteristics of critical 
thinkers, the importance of critical thinking for individual 
development and ways to encourage others to think 
critically. Most adults function as critical thinkers to 
some extent but the degree can vary dramatically from person 
to person. According to Brookfield, making judgments, 
choices, and decisions are examples of critical thinking. 
His work was used to support this research since patients 
were presented with the opportunity to think critically 
about treatment options. 
It is important to note that expected utility theory 
was investigated for its support and use with this research. 
The literature contained evidence to disprove its strength 
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and reliability when looking at attitudes towards risk or 
chance (Tversky & Kahneman, 1981) and in particular when 
studying patients with a life-threatening illness (Siminoff 
& Fetting, 1989). In place of the expected utility model, 
Tversky and Kahneman suggest a descriptive model called 
prospect theory. However, both expected utility theory and 
prospect theory were designed to predict choice and, since 
that was not the purpose of this study, neither were used 
for theoretical support. 
Definitions 
Chemotherapy 
Chemotherapy is the broad term for the classification 
of cancer-fighting drugs. There are approximately thirty 
different drugs that fall into this category. Different 
individual drugs and different combinations of drugs are 
used to treat the many forms of cancer according to the area 
of the body affected. Chemotherapy is most often available 
as an injectable solution, usually given intravenously, but 
is also available in tablet form. 
Decision Board 
The decision board is a visual aid designed to assist 
health care professionals to inform and teach the patient 
population about treatment options. The boards so far have 
been made of foam core and use bar graphs or pie 
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graphs/wheels and written material to communicate 
information. Presentation of the decision board is a 
building process. Cards containing the information are read 
aloud and then attached with velcro to the board in a 
particular sequence. 
Health Care Professional 
A health care professional refers to a nurse, 
physician, social worker, dietician or other professional 
disciplines that act as caregivers and members of the health 
care team. 
Medical Oncologist 
This term refers to a physician who has specialized in 
the treatment of cancer with medication such as chemotherapy 
or hormonal therapy. 
Patient 
This term refers to the person receiving health care. 
In this study the sample patients were premenopausal women 
newly diagnosed with Stage II breast cancer. 
Premenopausal 
This term refers to the reproductive status of a woman 
prior to experiencing menopause. 
Researcher 
In this study the researcher was a registered nurse 
employed as an Oncology Nursing Fellow in breast cancer at 
the Hamilton Regional Cancer Centre. This fellowship, and 
consequently this study, was funded by The Canadian Breast 
Cancer Foundation. 
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CHAPTER TWO: REVIEW OF THE LITERATURE 
This chapter begins with a review of the literature 
pertaining to the theoretical framework of adult education. 
This is followed by a summary of the research conducted in 
the area of patient decision making, related to oncology 
patients, and then a synopsis of the work that has been done 
to develop and implement the decision board concept. 
Andragogy and Self-Directed Learning 
The purpose of this section is to review the 
theoretical foundations of adult education specifically 
andragogy, self-directed learning, and critical thinking. 
Self-directed learning is a goal of andragogy and both 
include components of critical thinking. 
Malcolm Knowles (1975, 1980, 1984 & Associates, 1989, 
1990) is credited with having had the strongest influence on 
adult education since the mid 1970s. He introduced the 
European concept of andragogy to North America in 1968. 
Andragogy had been defined by European adult educators as 
"the art and science of helping adults learn" (Knowles, 
1990, p. 54). Originally, Knowles wrote about andragogy and 
pedagogy as a dichotomy, defining pedagogy as lithe art and 
science of teaching children" (Knowles, 1990, p. 54). 
However, he later revised his interpretation to view the two 
concepts as along the same continuum but at opposite ends. 
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Pedagogy refers to the traditional teaching model where 
learning is teacher-directed and the learner is dependent 
upon the teacher. Other assumptions that characterize 
pedagogy are: The teacher is responsible for deciding what 
and how a subject is to be learnedi the teacher's, not the 
learner's experience is valued; learners are told what and 
when they must learn; learning is subject-centred; and 
learner motivation comes from external pressures (Knowles, 
1990) . 
At the other end of the education continuum is the 
model of andragogy or learning that is learner-directed. 
The role of the teacher or facilitator within this model is 
to help the learner take increasing responsibility for her 
own learning to become self-directed. 
Andragogy is described by Knowles as a model of basic 
assumptions rather than a learning theory. It is most often 
used to refer to adult learners, but not exclusively. The 
basic assumptions of andragogy are summarized below 
(Knowles, 1990): 
The need to know. "Adults need to know why they need 
to learn something before undertaking to learn it" (p. 57). 
Once learners recognize the value of the new knowledge and 
how they can apply it, they are more likely to proceed with 
the learning endeavour. Therefore, one of the first tasks 
of a facilitator should be to help the learners become aware 
of their need to know. 
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The learner's self-concept. "Adults have a self-
concept of being responsible for their own decisions" 
(Knowles, 1990, p. 58). They also have a deep psychological 
need to be recognized by others as being capable of self-
direction, as well as taking care of themselves and their 
interests. Feelings of resistance or resentment may surface 
when an adult learner feels the beliefs or demands of others 
are being imposed. Frustrating situations can arise when 
adult learners, who are otherwise self-directing, present 
themselves in an educational setting and want to be taught, 
in a traditional sense, but at the same time expect to be 
treated as responsible and independent. Educators are 
responsible for providing a supportive environment and 
creating learning experiences to encourage the learner to 
move from dependency to self-directedness. 
Knowles (1980) identified five implications for 
practice that support the learner's self-concept: the 
learning climate; diagnosis of needsi the planning process; 
conducting learning experiences; and evaluation of learning. 
The physical and psychological learning climate should make 
adults feel at ease, respected, and supported. The 
diagnosis of needs emphasizes involving learners in the 
self-diagnosis of their learning needs. An ideal model of 
performance is constructed to which the learners compare 
their present level of competency, measure the existing gaps 
and identify learning needs. The process of planning 
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learning must involve the learner, with the educator acting 
as a guide and content resource. Conducting learning 
experiences is the mutual responsibility of the learner and 
teacher. The teacher's role is defined as a facilitator, 
resource person, and catalyst more than an instructor. The 
emphasis in this learning process is on self-evaluation with 
the teacher assisting the learner with gathering evidence 
regarding progress towards fulfilling learning needs. 
The role of the learner's experience. "Adults enter 
into an educational activity with both a greater volume and 
a different quality of experience from youths" (Knowles, 
1990, p. 59). In any group of adults there will be a wide 
range of individual differences which require an emphasis on 
individualization of teaching and learning strategies. 
Also, an adult learner's self-identity is defined based upon 
experience. This makes it especially important to accept 
and value the learner's previous experience, otherwise self-
identity may be threatened. 
Knowles (1980) identified three implications for 
practice related to the learner's experience. The first is 
to emphasize experiential learning techniques that 
acknowledge the experience of adult learners such as group 
discussion, role playing, seminars, and field projects. The 
second is to emphasize the practical application of new 
learning: that is, how learners can apply new knowledge to 
their every day lives. The third is unfreezing and learning 
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to learn from experience. Activities should be designed to 
encourage adults to look at themselves more objectively and 
to examine their preconceptions and open their minds to new 
approaches. 
Readiness to learn. "Adults become ready to learn 
those things they need to know and be able to do in order to 
cope effectively with their real-life situations" (Knowles, 
1990, p. 60). Readiness to learn must be assessed on an 
individual basis. A prime source for readiness in learning 
is the developmental tasks one encounters at all 
developmental stages. Although it may occur naturally, this 
readiness to learn can be encouraged in the learner. Often 
it may be important for the facilitator to consider the 
developmental stage of the learner in an attempt to 
coordinate the timing of developmental tasks with 
appropriate learning experiences. Consideration of 
developmental tasks is also helpful when trying to form 
groups of learners to ensure a common readiness and interest 
is present (Knowles, 1980). 
Orientation to learning. Adults are life-centred, 
task-centred or problem-centred rather than subject-centred 
(Knowles, 1990). Adults learn so that they can perform a 
task better, solve a problem or live in a more satisfying 
way. Adults are motivated to devote energy to learn 
something to the extent that they perceive that it will help 
them to cope with real-life situations. The emphasis is on 
the notion that learning experiences should be organized 
around life situations rather than according to subject 
areas. Adults are more likely to learn new knowledge 
effectively when it is presented in the context of 
application to real-life situations. 
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Knowles (1980) identified three implications for 
practice related to orientation to learning. First, the 
orientation of adult educators must be in tune with the 
existential concerns of adults so that they are able to 
develop relevant learning experiences. Second, the 
organization of the curriculum should follow a sequence that 
relates to problem areas, not subjects. Third is the design 
of learning experiences. The problem-centred approach 
stresses that the starting point for every learning 
experience is the problems or concerns that adults have as 
they enter a situation. The problems identified by the 
facilitator or institution should also be made known so that 
negotiation between the learner and facilitator can occur. 
Motivation. While adults may respond to external 
motivators such as job title or money, they are more 
responsive to internal motivators, such as job satisfaction, 
self-esteem and quality of life (Knowles, 1990). Adults are 
more motivated to learn when they see self-improvement as 
the ultimate goal. 
Knowles recognized that a learner will move along the 
continuum towards andragogy at her own individual pace and 
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that different individuals may be at different places along 
the continuum. This transition or movement is associated 
with both the developmental stage of the learner and the 
attitude of the educator (Knowles, 1975). A primary school 
teacher can practise methods based upon andragogical 
assumptions just as a university professor can practise 
methods based upon pedagogical assumptions. It is hoped 
that learners within our educational system are exposed to 
and encouraged towards following andragogy by the time they 
reach the post-secondary level if not sooner. Similarly, 
within the health care system there can be a wide range of 
teaching methods and strategies used by health care 
professionals to facilitate patient education. 
In following the andragogical model, an educator needs 
to concentrate on the learning process more so than the 
actual subject area (Knowles et al., 1984). He found the 
following elements to be necessary for the practice of 
andragogy: 
1) Establishing a physical and psychological climate 
conducive to learning is very important. The physical 
environment should be comfortable and conducive to 
communication among the learners. The psychological 
environment should include an atmosphere of mutual respect, 
trust, collaboration, support, pleasure, openness and 
authenticity and humanness. 
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2) Learners should be involved in mutual planning. A 
mechanism needs to be in place within the learning 
environment that allows for this. People tend to feel more 
committed to a decision when they have participated in 
making it. 
3) Participants should be involved in diagnosing their own 
needs, formulating their learning objectives, designing a 
learning plan, and evaluating their learning. Facilitators 
need to be available to guide and assist learners in 
carrying out their learning plans. Evaluation includes 
evaluating the accomplishments of individual learners as 
well as the quality of the whole program. 
Knowles (1975) believed self-directed learning was 
effective for several reasons. First, "people who take the 
initiative in learning learn more things" (p. 14) than 
passive learners. Second, "self-directed learning is more 
in tune with our natural processes of psychological 
development" (p. 14). As we grow and add to our experience 
we develop a need to be independent. Third, some aspects of 
education have led to increased learner responsibility, 
thereby increasing the need for support to enable students 
to cope with this. As a result, the main purpose of 
education has shifted towards encouraging the development of 
skills of inquiry rather than simply transmitting knowledge. 
Learning is a lifelong process since we learn from all our 
experiences. The ability to learn on one's own has become a 
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prerequisite for living in a rapidly changing society. 
Knowles' assumptions have important implications for health 
care professionals working with adult patients. Disease, 
procedures and treatments often interfere with personal 
privacy, self-esteem and individuality. Adults seek 
information about their health to increase their knowledge 
and understanding, to enable participation in their own 
care, to maintain control, and to maximize their quality of 
life. Health care professionals should consider the 
principles of andragogy when educating patients. 
Philip Candy (1991) provided a comprehensive and 
thorough discussion of self-directed learning in his book 
Self-Direction for Lifelong Learning. Candy emphasized that 
self-directed learning can be interpreted in two different 
ways, as a goal of education and as a method of learning. 
Each of these interpretations is comprised of two distinct 
dimensions. As a goal or outcome of education, self-
directed learning is subdivided into the domains, personal 
autonomy and self-management. As a method or learning 
process, self-directed learning is subdivided into the 
domains autodidaxy and learner-control. These four areas 
are defined by Candy as the four distinct but related 
phenomena of self-directed learning. Discussion will centre 
around personal autonomy and autodidaxy. 
Personal autonomy, when referred to with regards to 
self-direction, has two meanings (Candy, 1991). The first 
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is the broad definition of "thinking and acting autonomously 
in all situations" (p. 101) also referred to by Candy as 
self-determination. The second is what Candy referred to as 
self-management, meaning "to exert control over one's 
learning endeavours" (p.101). Therefore, in this paper, the 
use of personal autonomy or self-determination refers to the 
first definition while the term self-management is used to 
refer to the second meaning. 
The personal autonomy of an individual may be judged 
based upon the extent to which he or she conceives goals and 
plans and formulates independent intentions, exercises 
freedom of choice in thought and action, uses rational 
reflection and is able to judge what is morally right with 
objectivity and relevant evidence, has will power to follow 
through with plans of action without having to depend on 
others for reassurance, exercises self-restraint and self-
discipline in emotional or challenging situations, and views 
himself or herself as autonomous (Candy, 1991). This is to 
say that one is able to develop a personal agenda of 
objectives and make independent decisions using a sound 
rationale. An autonomous person has the strength and 
endurance to see ideas further develop through to completion 
without relying on the support of others. Candy 
acknowledged that this definition represents an ideal 
profile of an autonomous person and therefore it is likely 
that few people are able to achieve autonomy in the 
strongest sense. 
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So how does one become autonomous? The ability to 
become personally autonomous increases with age and can be 
further developed through learning experiences (Candy, 
1991). It is not purely maturational nor is it based upon 
educational experience alone. The continuing development of 
personal autonomy is a lifelong pursuit involving both 
formal and informal aspects of education and all aspects of 
the individual (Candy, 1991). 
Autonomy is not simply a personal quality or 
characteristic but is the interacting relationship between 
personal and situational variables (Candy, 1991). One does 
not just become autonomous, but rather is able to think and 
act autonomously in certain situations. A person can vary 
in the degree of autonomy exercised from situation to 
situation. One can be autonomous in some areas and not 
others. 
Adults are presumed to be self-determining individuals 
but are not always capable of exercising control over their 
own learning; however, this ability can be learned (Candy, 
1991). Autonomy cannot be detected from behaviour alone but 
must take into consideration the learner's intentions and 
understanding. 
Freedom for a learner in a learning situation does not 
guarantee autonomy. One cannot give someone autonomy or 
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force someone to be autonomous but one can provide the 
supportive environment necessary for autonomous qualities to 
grow. 
The link between the enhancement of personal autonomy 
and autonomous methods of learning can create some 
confusion. Individuals may be exposed to autonomous modes 
of learning without internalising the values of autonomy and 
conversely may develop autonomy without the exposure to 
autonomous methods (Candy, 1991). Personal autonomy is not 
meant to encourage antisocial behaviour. Autonomy involves 
co-operation, flexibility and mutual respect from contact 
with and support from others. Cranton (1992) reinforced 
that for learning to occur there must be interaction between 
the learner and the environment. 
The development of personal autonomy is supported by 
society as an educational goal; however, the degree of 
emphasis placed upon personal autonomy will vary according 
to the learning situation (Candy, 1991). Since autonomy is 
a process, rather than a product, it should serve as the 
goal of lifelong education not only that of adult education. 
Autodidaxy refers to the independent pursuit of 
learning opportunities in natural societal settings (Candy, 
1991). This kind of learning has been taking place since 
the beginning of time and accounts for by far the majority 
of learning that takes place everywhere in the world. 
People have always encountered new situations and as a 
result have entered into the learning process to gain 
understanding about an unending number of subjects. 
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Autodidaxy is learner-centred and requires initiative 
on behalf of the learner (Candy, 1991). It is not a 
teaching method or technique of instruction. It involves 
aspects of teaching such as goal setting, searching for 
resources, attacking the subject matter, responding to 
feedback, and evaluation (Candy, 1991). However, autodidaxy 
is not a set process. It unfolds with time and is therefore 
an unpredictable process. The impact of random events leads 
to rethinking and reorganizing plans as the project 
proceeds. 
Autodidactics are usually purposeful, disciplined 
learners who are alert to learning opportunities in a 
variety of situations. Autodidaxy is often social and does 
not infer isolation. Much autodidactic learning occurs 
within group settings such as local community groups. 
Autodidactic learners may make use of a wide variety of 
resources such as individual experts, written material, 
media and computer programs (Candy, 1991). Tough (1967) 
suggested that autodidactics seek assistance for four 
reasons: unfamiliarity with the area of interest; a lack of 
knowledgei a need for emotional support and encouragement; 
and to get help with specific problems or information. 
The resource person (assistant) chosen by an 
autodidactic needs to be flexible to the needs of the 
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learner, have knowledge of the subject matter, have interest 
in the welfare of the learner, and be an effective 
communicator (Candy, 1991). Advantageous communication 
skills should include listening, empathy, respect, and 
encouragement of learner self-confidence. 
According to Candy, the relationship between an 
autodidactic and assistant is an area that has not been well 
researched; however, he explained four potential 
relationships that may develop between the learner and the 
assistant. These are the relationships between a mentor and 
/ / protege, an advisor and graduate student, a counsellor and 
client, and a librarian and library user. within this 
framework, my role as the researcher and the patient's role 
as the learner parallel the counsellor-client relationship 
the most closely of the four. 
Criticisms of Andragogy and Self-Directed Learning 
Andragogy and self-directed learning have prompted 
debate and controversy over the past few decades. Adult 
educators and theorists have tried to further clarify self-
directed learning through critical analysis. Some of the 
constructive criticisms of Brookfield (1985, 1986) and 
Cranton (1992) are discussed. 
Stephen Brookfield is well known for his contributions 
to the study of adult education and, in particular, self-
directed learning. In fact, he has written the most 
complete analysis of andragogy and Knowles' work available 
to date. His work provided the primary criticism of 
andragogy in this review. 
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Brookfield (1986) recognized that Knowles correctly 
described andragogy as a "model of assumptions ... not an 
empirically based theory of learning" (p. 91). However, the 
misinterpretation of others in this regard has led to some 
confusion. "Brookfield does not criticize the work of 
Knowles himself so much as the use of Knowles' work by 
others" (Cranton, 1992, p. 15). Brookfield himself 
incorporated some of Knowles' ideas into his own work, but 
still suggested that both pedagogy and andragogy need to be 
critically challenged by educators so that more evidence can 
be collected. 
Brookfield (1986) found that most of the research 
related to self-directed learning has been conducted with 
samples of white, male, middle-class, well-educated adults. 
Therefore, the generalizability of the results are rather 
limited based upon gender, race, culture and educational 
level. This leads back to the fact that one of the basic 
assumptions of andragogy is that learners prefer to be and 
have a deep psychological need to be self-directing. 
However, with research limited to a specific population, one 
cannot be sure how it applies to other cultures and 
societies. Cranton (1992) also noted this as a criticism. 
Brookfield (1986) stated that "while self-directedness is a 
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desirable condition of human existence it is seldom found in 
any abundance" (p. 95) throughout the world. Therefore, 
perhaps self-directed learning is more characteristic of 
middle class North American culture and is not as global a 
quality as we are led to believe. 
It should be mentioned that Knowles (1990) did not 
claim that all learners are self-directed but rather that 
they have a need to be and recognized as self-directed. 
Caution should be taken so as not to assume that everyone in 
all learning situations wants to be or is capable of being 
completely self-directed. The degree of self-direction is 
bound to vary among different individuals depending upon the 
learning situation. Preference for and ability to 
participate in self-directed learning may also be affected 
by the outcome of other characteristics such as 
developmental stage, psychological type, and learning style 
(Cranton, 1992). Candy (1991) supported this and Knowles 
(1989) admitted that there are learning situations where 
self-directed learning is not recommended as the best 
approach, such as those involving protection of life. 
Brookfield (1985) was also critical that learning and 
adult education are always portrayed as being enjoyable and 
rewarding. Rarely is an adult made aware that his/her 
learning experience may cause feelings of anxiety, ambiguity 
and self-doubt. It is evident that not all adult learners 
easily adapt to the self-directed role or, for that matter, 
the learner role in general. In particular, self-directed 
learning can be very distressing for some, even those more 
experienced with the process. 
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According to Knowles (1990) there are skills required 
to be a self-directed learner and, as Cranton (1992) noted, 
these skills are "not ones which the average adult brings to 
a learning experience" (p. 50). These skills can be 
fostered given a conducive learning environment, but we 
cannot expect learners to always arrive with a previous 
awareness of them. 
One of Brookfield's main complaints about self-directed 
learning is the role of the educator as only a resource 
person to help meet the needs of the learner. Brookfield 
(1985) argued that the educator should be responsible for 
contributing to the direction of learning and should be 
involved in the discussion of appropriate curricular 
choices. Educators are at risk of abdicating their role by 
allowing learners to solely determine the design and 
management of their personal course of learning (Brookfield, 
1985). In addition, Brookfield pointed out that there is 
yet to be established a set of criteria for measuring the 
purpose, success or appropriate curricula for the level of 
adult education within an activity. Until this is achieved, 
this can only add to the helplessness of the educator role. 
Brookfield (1985, 1986) believed self-directed learning 
involves a process of internal change in consciousness for 
the learner. Central to this process is critical 
reflection, also known as critical thinking. Brookfield 
criticized those who fail to recognize the internal 
happenings in addition to the external behaviours of self-
directed learners. 
Critical Thinking 
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In addition to self-directed learning, Brookfield 
(1987) has explored the concept of critical thinking as a 
component of adult learning. He defined critical thinking 
as an activity undertaken by all individuals as part of 
normal development. It occurs whenever we question our 
underlying assumptions and investigate possible alternatives 
to our ways of thinking and acting. Brookfield described 
five characteristics of critical thinking. They are 
summarized below: 
"Critical thinking is a productive and positive 
activity" (Brookfield, 1987, p. 5). Critical thinkers are 
people actively involved in life. They are innovative, 
open-minded, and they appreciate creativity. They recognize 
opportunities and the potential for change and have the 
self-confidence to take action. 
"Critical thinking is a process, not an outcome" 
(p. 6). It is an active process of continually questioning 
assumptions. It is not a stage that one completes as there 
is no end point for complete critical development. 
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"Manifestations of critical thinking vary according to 
the contexts in which it occurs" (p. 6). A wide variety of 
signs may indicate the critical thinking process is 
happening. The event, environment, and personal 
characteristics of the individuals involved affect whether 
critical thinking is noticeably visible. 
"Critical thinking is triggered by positive as well as 
negative events" (p. 6). A tragedy as well as a joyful 
event can cause people to question their assumptions and re-
evaluate their role and meaning. 
"Critical thinking is emotive as well as rational" 
(p. 7). Challenging previously accepted ideas, beliefs and 
behaviours is anxiety-provoking for most individuals. 
Feelings of resistance, confusion, uncertainty, joy, and 
relief are often part of the process at some point. 
Generally, everyone engages in critical thinking at 
some point in their lives. The amount and extent of 
critical thinking may vary from person to person. If we did 
not ever use our critical thinking abilities we would live 
by previously established rules and standards and nothing 
would ever change. This would have a profound effect on 
individuals and society as a whole. 
Brookfield (1987) emphasized four components of 
critical thinking. The first is identifying and challenging 
assumptions. This component is central to the critical 
thinking process. This occurs when people examine their 
patterns of thinking and behaviour to reveal their 
underlying values and assumptions. They then begin to 
question these assumptions and wonder if they are still 
effective given what is happening in their lives. 
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The second component is understanding the importance of 
context to critical thinking (Brookfield, 1987). This is a 
major outcome of identifying and challenging assumptions. 
Contextual awareness comes from the realization that there 
are many possible influences, some less obvious than others, 
that shape our interpretations and assumptions. For 
example, culture and history influence many of our 
assumptions. "Critical thinkers are aware that practices, 
structures, and actions are never context-free" (Brookfield, 
1987, p. 8). When we appreciate the context in which our 
assumptions are framed we can fully understand our actions 
and beliefs. 
The third component of critical thinking is to imagine 
and explore alternatives. This involves searching for ideas 
and actions that will have greater meaning for the 
individual. This is possible when people understand that 
alternative ways of thinking and acting exist. This 
realization can be liberating because we see there are other 
options available to replace beliefs or behaviour with which 
we are dissatisfied. It can also be a threatening 
experience to admit that we may have misplaced trust and 
meaning in our beliefs. 
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The fourth and last component of critical thinking is 
reflective skepticism. We develop reflective skepticism 
when we become suspicious of the validity of claims made by 
others. Justification such as "because that's the way it 
is" is not taken for granted but rather is challenged and 
tested. 
Brookfield (1987) described five phases of the critical 
thinking process: the trigger event, appraisal, 
exploration, developing alternative perspectives, and 
integration. It is necessary to move through all five 
phases for change to occur. 
The trigger event is an unexpected happening, positive 
or negative, that initiates a sense of inner discomfort or 
disequilibrium in one's life. Some events are more shocking 
than others and therefore the critical thinking process may 
begin without the individual being aware of the process. A 
policy change at work, the beginning of a new relationship 
or the diagnosis of a life-threatening illness are examples 
of trigger events. 
Appraisal is the time period following the trigger 
event during which self-examination occurs. This involves 
further examination of the event and its meaning as well as 
the impact upon the individual. It may also involve partial 
denial of the event and a search for others in a similar 
situation. 
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Exploration begins once the realization of a 
discrepancy present in some aspect of life has occurred. 
This starts the search for new ways of explaining or coping 
with the disequilibrium caused by the event. During this 
phase alternative ways of thinking or acting are tested to 
help reduce the level of discomfort felt by the individual. 
Alternative perspectives are developed following the 
testing and exploration of new options. Perspectives are 
selected from those assumptions that have been found to be 
the most congruent with our lifestyle and quality of life. 
The adoption of new assumptions often means abandoning old 
ones that are no longer appropriate or of value. This part 
of the phase may be difficult for some individuals, 
depending on the circumstances. 
Integration is the final stage in which the newly 
acquired perspectives are accepted into our way of life. 
This occurs once the worth and validity of the new 
perspectives have been established. 
Contact with other individuals plays an important role 
in the critical thinking process (Brookfield, 1987). The 
process can be disturbing and unsettling for some 
individuals. It can also generate confusion and doubt. 
Therefore the presence of family, friends, or professionals 
can provide the opportunity for discussion and emotional 
release. The assistance of others can help alleviate some 
of these feelings and add clarity to the situation. There 
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are usually several opportunities for education and guidance 
during the process that will help to encourage and support 
the critical thinker. 
Brookfield (1987) suggested some effective strategies 
for facilitating critical thinking in others. The first 
strategy is to affirm the learner's self-worth. It is 
important not to threaten the learner's self-concept. 
Second, attentive listening to verbal and nonverbal cues can 
help to understand the person's perspective and where he/she 
is at in the process. Brookfield suggested that one show 
support for such efforts. Beginners in particular need 
support when challenging assumptions they have held all 
their lives. Fourth, it is helpful to reflect back to the 
learners their attitudes and rationalizations. This is an 
effective communication skill for providing clarity. 
Lastly, facilitators of critical thinking should support 
social networking among critical thinkers and encourage 
regular evaluation of their progress. 
Motivating people to think critically and raising their 
awareness of how to learn the process is an important task. 
Role models play a key part in fostering the desire and 
potential for change to occur. When offering guidance, 
consideration of the context is crucial to identifying the 
most effective ways of assisting individuals to realize 
their ideas and the alternatives available. 
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Patient Decision Making 
The role of patients in medical decision making has 
become increasingly important. Generally, research has 
indicated that more and more patients prefer to be informed 
and involved, at least to some extent, in decisions 
regarding their own care. The traditional role of the 
patient has faded and a contemporary role emerged. The 
traditional role conceptualized the patient as the passive 
recipient of care with an unquestioning belief that the 
physician knew best for the individual. The contemporary 
role allows for increased patient participation in the 
management of his or her own health care while acknowledging 
individuality and personal preference. This provides the 
client with the information and, under appropriate 
circumstances, the opportunity to participate in decisions 
regarding care. 
Oncology health care professionals are often confronted 
with treatment decisions that will have an impact on the 
patient's quality of life. In these instances both the 
risks and benefits must be considered and a choice made with 
the patient's best interest at the centre of the issue. Who 
is better able to provide the necessary insight into a 
patients's desired quality of life than the patient? As a 
result, the concept of shared decision making, also referred 
to as shared control, between the patient and health care 
team is now practised more often than ever before. Many 
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studies have investigated patient participation and decision 
making including the preferences of oncology patients in 
particular. From these studies certain themes have emerged. 
Several studies have indicated that the majority of 
patients prefer to share treatment control with their 
physicians (Cassileth, Zupkis, Sutton-Smith, & March, 1980; 
Hack, Degner, Farber, & McWilliams, 1992). Degner and 
Russell (1988) measured the preferences for treatment 
control among 60 adult oncology patients at two cancer 
centres in Manitoba. Their results indicated that patients 
wanted to be involved in the treatment decision-making 
process and that joint control between the patient and 
physician was preferable. More than half of this sample 
consisted of women with breast cancer. 
It is apparent from the literature that when referring 
to shared decision making there is a range in the degree of 
participation patients desire. Although a standardized 
definition has yet to be developed and recognized for shared 
decision making and treatment control in the health care 
context, it can be said that this concept refers to mutual 
discussion and negotiation between the patient and the 
health care team with neither party having exclusive 
control. 
Another finding from the research is that those 
patients who prefer the more active role are often female, 
younger and well-educated (Hack et al., 1992). Cassileth 
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et a1. (1980) studied patients' preferences for active 
versus passive participation in their medical care and 
desire for treatment-related information. In a sample of 
256 cancer patients, both outpatients and inpatients, the 
majority welcomed more information and the opportunity to 
play an active role. In particular, younger and more 
educated patients preferred to participate in treatment 
decisions while older and less educated patients preferred 
to have the physician make those decisions. Blanchard, 
Labrecque, Ruckdesche1, and Blanchard (1988) examined the 
interactions between 89 cancer patients and five medical 
oncologists and found that those who chose an active role in 
decision making were female and younger in age versus those 
who wanted to remain passive. Degner and Sloan (1992) also 
discovered that those cancer patients who preferred active 
involvement were younger, well-educated and were often women 
with a reproductive cancer such as breast cancer. In 
addition, there was some evidence that patients who were 
separated, divorced, or not married were more likely to 
desire an active role in treatment decision making 
(Blanchard et a1., 1988; Ende, Kazis, Ash, & Moskowitz, 
1989) . 
The literature also revealed that patients offered 
participation in treatment decisions show better 
psychological adjustment than patients not given a choice 
(Hack et a1., 1992). Ende et a1. (1989) found that the more 
actively involved patients were more satisfied with their 
medical care and how their decisions were being made. 
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Owens, Ashcroft, Leinster, and Slade (1987) concluded that 
offering women with breast cancer a choice between surgical 
treatments was important for positive psychological 
adjustment. Morris and Ingham (1988) conducted an 
experimental design study with early stage breast cancer 
patients referred for surgical treatment and their husbands. 
The experimental group was offered the choice between a 
mastectomy and breast conserving surgery plus radiation. 
Regardless of the type of surgery chosen, the women and 
husbands in the experimental group demonstrated overall 
better psychological adjustment to the cancer experience 
than the control group. The results from Morris and Royle 
(1988, cited in Hack et al., 1992) and Fallowfield, Hall, 
Maguire, and Baum (1990) also indicated that breast cancer 
patients who were offered a choice between surgical 
treatments experienced less anxiety and depression than 
those not offered a choice. Dennis (1990), when studying a 
group of patients with mixed diagnoses, found that cancer 
patients in particular desired active involvement in 
decision making and that information helped reduce anxiety 
and uncertainty. 
Increased patient participation may improve patient 
compliance and hope for a favourable outcome (Hack et al., 
1992). Cassileth et al. (1980) found that patients who were 
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actively involved in their own care were significantly more 
hopeful about their situation. This provides support for 
health care professionals to help patients to become well-
informed and to be less fearful of the risk of increasing 
patient anxiety. However, some exceptions do apply. 
It is important to note that these studies also found 
that some patients do not want to participate in treatment 
decision making; however, the literature provided much 
support that young women with breast cancer are among those 
who do desire a more active role in their treatment decision 
making. 
Following this, it is important to offer patients the 
option to participate and not assume that they desire an 
active role. Hack et al. (1992) found that physicians may 
misperceive the degree to which patients want to participate 
in decision making. Strull, Lo, and Charles (1984) also 
reported physicians often overestimate the extent of 
involvement patients desire. In addition, a few studies 
comparing the opinions of cancer patients to healthy adults 
have found that healthy adults are more likely to claim 
preference for active involvement in treatment decision 
making than those faced with life-threatening disease 
(Degner & Sloan, 1992). 
Hack, Degner, and Dyck (1994) studied 35 women with 
early stage breast cancer and found that patients who 
desired an active role in treatment decision making also 
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desired detailed information; however, the relationship for 
those patients who preferred a passive role was not clear. 
Cassileth et ale (1980) found a strong correlation between 
preference for information and desire to participate in 
decisions suggesting that these two components represent one 
approach. However, conflicting results come from a study by 
Ende et ale (1989) involving 312 medical patients. They 
found no correlation between patients' decision making and 
information seeking preferences. To provide clarity for 
this paper, I have not assumed that a patient's desire for 
information is the same as a patient's desire for 
participation in treatment decision making. This accounts 
for situations in which a patient wants to be informed yet 
prefers that the physician maintain control of treatment 
decisions. 
The only study I found that investigated the factors 
that affect treatment decision making for women with breast 
cancer was conducted by Ward, Heidrich, and Wolberg (1989). 
Twenty-two women aged 38 to 77 years were offered the choice 
between surgical treatments. Two factors were found 
significantly different between the women who chose breast 
conservation surgery and those who chose a modified radical 
mastectomy. The factors were concerns about body integrity 
and radiation therapy respectively. In addition, these 
women reported that participation in decision making was 
important to them and they rated people sources of 
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information as more important than written or visual. The 
method of information presentation was a verbal description 
given by the surgeon, followed by a videotape presentation, 
then a handout, and lastly review of the information by a 
nurse. It is important to note that an interactive decision 
instrument was not used. 
This literature represented both quantitative and 
qualitative research done in Canada and the United States 
since 1980. Almost all of these studies involved women with 
breast cancer and several reported on young women with early 
stage breast cancer. In some cases limitations such as 
small sample size, wide age range, variety of disease sites, 
multiple presenters of information, mortality bias, and 
selection bias were noted. Despite this the results 
remained fairly consistent. 
The effect of framing, with regards to decision making, 
has been investigated in the literature. Framing refers to 
the context in which information is presented in terms of 
wording and phrasing. O'Connor, Boyd, Tritchler, Kriukov, 
Sutherland, and Till (1985) found that the framing of facts 
and scenarios influenced people when the medium used and 
characteristics of the interviewer did not. Their sample 
consisted of nursing students, patients, family members, and 
the general public who, when asked to compare positive and 
negative framing of treatment scenarios, chose the treatment 
that included the use of the term "survive" versus "death." 
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The presence of the term "survive" was found to be the major 
source of framing bias. However, this bias can be 
controlled by presenting treatment options using the same 
framing pattern. It is noted that only a portion of this 
sample were oncology patients and patient perspectives vary 
from those of non-patients. 
O'Connor (1989) also found cancer patients' preferences 
to be influenced by framing and level of probability, that 
is chance of survival or death. In addition, this study 
noted a significant difference between the choice of toxic 
therapy by cancer patients versus those of healthy subjects. 
Cancer patients chose treatment more often even if the 
survival benefit was minimal. Other studies have often used 
samples of healthy people. 
Siminoff and Fetting (1989) found no significant 
associations between the framing of treatment outcome and 
the type of treatment chosen with a sample of breast cancer 
patients. The physician's treatment recommendation was the 
strongest indicator of treatment decision. 
The literature about the effect of framing on decision 
making is inconclusive. A mix of positive and negative 
framing was used within the description of each chemotherapy 
regimen on the decision board and in the script. 
Decision-Making Behaviour 
Two studies examined the patterns of behaviour 
demonstrated by women with breast cancer involved in 
treatment decision making. 
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Hilton (1994) investigated family decision-making 
processes about treatment (surgery, radiation, and 
chemotherapy) for early stage breast cancer. Using a 
qualitative approach, 55 women with breast cancer and their 
families were followed to reveal four patterns of family 
decision making: defer to physician; minimal exploration: 
joint engagement; and extensive, deliberate examination. 
They are listed in order from the lowest to the highest 
degree of participation in care. 
Pierce (1993) conducted a qualitative study to 
investigate the decision-making experience of 48 women with 
early stage breast cancer when given a choice between two 
surgical treatments. Using grounded theory she described 
three styles of decision-making roles: the deferrer, 
delayer, and deliberator. 
Subjects in the deferrer group appeared to be drawn 
towards one particular option. These women made quick, 
conflict-free decisions, often following what they perceived 
to be the physician's recommendation. Usually the decision 
was made without considering all the attributes of each 
option. Although they accepted responsibility for making 
their decision, they often deferred the responsibility for 
the outcome onto the physician, fate, or God. They declared 
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a preference for their choice based upon immediate appeal 
with no deliberation or search for other sources of 
information. This group was averse to risk and, regardless 
of choice, felt they had chosen the safest method. The 
decision experience was simple and straightforward. 
Subjects reported that there was no decision because they 
had not considered the other option. They did not know how 
they made their choice and many did not believe they had 
made a choice. Patients reported satisfaction with their 
decision and did not anticipate regret later. Subjects in 
this group were the oldest in age and accounted for 41 
percent of the sample. 
Subjects in the delayer group considered at least two 
options and separated the information into manageable parts. 
Their deliberation is described as random and superficial as 
they often jumped from the consideration of one option to 
another. The women appeared to respond to a particular 
aspect of each option rather than to the total picture. 
They compared the two choices until the first difference 
between them was perceived and then a decision was made. 
Subjects were satisfied with their decision. This group was 
also averse to risk and information sought was usually of 
the popular variety such as magazines. Subjects in this 
group were younger than the deferrers and accounted for 44 
percent of the sample. 
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Subjects in the deliberator group "expressed a personal 
responsibility for making a quality decision" (Pierce, 1993, 
p. 26). These women were unique because their action was 
purposeful, using a strategy or plan. They also considered 
risk, expressed confidence in the decision-making process, 
yet had lingering uncertainty about the outcome and 
anticipated regret at some point in the future. Their 
mental strategy involved laying out a plan to look at the 
attributes of each alternative. This was followed by an 
extensive information search including expert consultation. 
A decision was made only when the subject was confident she 
had considered all relevant information and found an 
alternative that satisfied her major requirements. These 
subjects sought control and identified events beyond their 
control. They did not experience immediate satisfaction 
with their decision but rather described a feeling of 
confidence with the process. The women in this group 
experienced by far the most psychological distress and 
accounted for 15 percent of the sample. 
The results from Pierce's study are enlightening as she 
is the first to try to describe the decision-making 
behaviour of women with breast cancer. Limitations such as 
age, physician presentation and the small sample size were 
noted. The wide age range, 25 to 90 years, could account 
for different preferences of surgical treatment as well as 
approaches to decision making. The presentation of 
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information by the physicians was not controlled and 
therefore likely varied from physician to physician. Also, 
without a standardized format, the presentation of 
information was possibly influenced by patient 
characteristics such as age and everyday variability from 
situation to situation. 
The Decision Board 
In the past, health professionals have attempted to use 
a variety of presentation methods and designs for the 
purpose of patient education. In a study conducted by 
Miller and Shank (1986), the effectiveness of three 
different methods of presenting patient educational material 
were compared. Their findings suggested that the presence 
of a health professional to present and review information 
with the patient is an effective method in terms of patient 
learning, information retention and compliance. 
The concept of a decision board was developed at the 
Hamilton Regional Cancer Centre only within the last few 
years; therefore, the literature available is very limited. 
The decision board was developed to present information 
obtained from clinical trials, with respect to quality of 
life, to patients to encourage the process of shared 
decision making regarding treatment options. 
The first decision board was developed to describe 
treatment information to patients with Stage I breast 
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cancer. Specifically, the board was designed to objectively 
present the risks and benefits of chemotherapy to an 
individual. As the result of a simple process, an informed 
patient could make a personal choice (Levine et al., 1992). 
The patient's choice was "chemotherapy" or "no 
chemotherapy." For women with Stage I disease chemotherapy 
provides a modest benefit, perhaps, at the risk of greater 
side effects. The board presented information on the 
possible outcome and quality of life for both options. The 
instrument was proven to be reliable and valid with a sample 
of 30 healthy volunteers (Levine et al., 1992). Reliability 
was tested by administering the same board to the same 
subjects on two separate occasions. Following each 
presentation the subject was asked to indicate the strength 
of her preference using a Likert scale. In between the 
reliability tests, validity was evaluated by changing the 
information about risks and benefits to determine whether 
preferences changed in a predictable manner (Levine et al., 
1992) . 
The second decision board was also developed to 
describe treatment information to patients with Stage I 
breast cancer but, in this case, for those eligible for 
radiotherapy. This board presented the advantages and side 
effects of radiation treatment, as well as the outcome and 
effect of treatment on long-term survival. The patient's 
choice was "radiation" or "no radiation." The choice of 
radiation therapy offered no survival advantage but rather 
an increased chance of avoiding a recurrence of cancer in 
the breast and subsequent surgery (Whelan, 1993). The 
researcher using this board investigated the gap between 
information provided by the physician and patient 
understanding. 
Summary 
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This review of the literature has demonstrated that 
self-directed learning and critical thinking are important 
goals of adult education in general. In recent years adult 
education has taken on an important role for patients as 
consumers within the health care system. In many ways 
patients have been allocated greater responsibility for 
their own care. As the number of people diagnosed with 
cancer continues to grow so has the concern for quality of 
life. As a result there are an increasing number of 
opportunities for patient education so that in some 
situations they may have the chance to participate in their 
treatment decisions. One aspect of understanding how people 
make decisions and think critically regarding their health 
is to inquire about what issues are most important to them. 
The intent of this study was to investigate what factors 
affect the treatment decision-making process for women with 
breast cancer. 
CHAPTER THREE: METHODOLOGY 
The purpose of this research project was to examine the 
factors that influence the decision made by a woman with 
breast cancer when given a choice between two 
chemotherapies. To further understand the decision-making 
process each individual's learning and quality of life were 
investigated. 
Design 
The study followed an empirical-analytical research 
paradigm. This quasi-experimental design involved a two-
group comparison using survey data. 
Sample 
The study sample was 30 premenopausal women newly 
diagnosed with Stage II breast cancer. The sample was 
recruited from the new patient clinic at the Hamilton 
Regional Cancer Centre for 26 consecutive weeks. Up to 
three new patients (of any age), per physician, were seen in 
this clinic weekly on Thursdays. Three medical oncologists 
regularly worked in this new patient clinic with the help of 
other medical and nursing support staff. 
Eligibility criteria were as follows: 
A diagnosis of Stage II breast cancer; 
Premenopausal statusi 
Post-surgery for removal of breast cancer; 
English speaking and fully literate; and 
Written consent to comply with completing 
questionnaire. 
Instruments 
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The instruments used for this study were a decision 
board and a questionnaire. They are included in Appendices 
A and B. 
The decision board design somewhat followed that of the 
two previously developed boards. The content was chosen by 
me with input from the staff of the breast clinic. It was 
based upon the literature and my own clinical experience in 
attempting to meet the informational needs of patients and 
their families. Prior to implementing the decision board, 
feedback was obtained from several nurses and physicians at 
the Cancer Centre as well as other patients with breast 
cancer. A written script was developed to accompany the 
decision board (see Appendix C). The script was tested and 
found to be at a Grade Eight readability level using the 
SMOG test (Redman, 1988). 
The questionnaire was mainly quantitative in design 
with four sections: The first included demographic 
information; the second was about how and why each woman 
made her decision; the third tested learning from the 
decision boardi and the fourth gathered baseline information 
about quality of life. The questionnaire was original 
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except for section four, The Functional Assessment of Cancer 
Therapy Scale by Cella, Tulsky, Gray, Sarafian, Linn, 
Bonomi, Silberman, Yellen, Winicour, Brannon, Eckberg, 
Lloyd, Purl, Blendowski, Goodman, Barnicle, Stewart, MCHale, 
Bonomi, Kaplan, Taylor, Thomas, and Harris (1993) . The 
authors reported coefficients of reliability and validity 
that were uniformly high. Quality of life item numbers 8, 
16, 19, 25, 33, and 43 were excluded from data analysis 
because during questionnaire administration many subjects 
verbalized some uncertainty about how to interpret these 
statements. Inter-item correlations are reported in 
Appendices D and E. 
In an effort to take into account order of 
presentation, two versions of the decision board, the script 
and the questionnaire, were administered to patients. These 
are labelled "version One" and "Version Two" and can be 
found in Appendices A and F. This was done to determine 
whether the order in which the chemotherapy options were 
presented affected patients' choices. Appropriate changes 
were made to the script and questionnaire to coincide with 
the decision board version used. 
pilot Test 
A pilot test was performed using seven healthy 
volunteers and four new patients. This was to ensure that 
the information on the decision board and questionnaire were 
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understandable. All individuals chosen had not been exposed 
to this information previously. All subjects were 
administered Version One of the decision board and 
questionnaire. 
The volunteer group consisted of seven women aged 25 to 
44 years of age. These individuals varied with regards to 
marital status, number of children, employment, level of 
income, education, and religion. 
The volunteers were administered the decision board on 
two separate occasions between one and three weeks apart in 
a home or work setting. Immediately following the 
presentation each woman was asked to complete the 
questionnaire, sections one, two, and three only. 
Therefore, each volunteer completed the questionnaire twice. 
The volunteers were not asked to complete section four of 
the questionnaire because the reliability and validity of 
the quality of life tool was previously established 
(Cella et al., 1993). 
Of these seven women, three chose AC and four chose 
CMF. All commented on finding the decision board helpful 
and the information clear and concise. Every volunteer 
answered all the learning questions correctly and a variety 
of reasons were given for their choice of chemotherapy. 
The patient group consisted of four premenopausal women 
newly diagnosed with Stage II breast cancer seen at the 
Hamilton Regional Cancer Centre following surgery. They 
ranged in age from 36 to 46 years of age. This group also 
varied with regards to marital status, number of children, 
employment, level of income, education and religion. 
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I presented the decision board to each patient in one 
of the clinic rooms following her consultation with the 
medical oncologist. Each woman was given a copy of the 
information to take home and asked to return one to two 
weeks later with her decision made. At this time each woman 
was asked to complete the entire questionnaire. Therefore, 
each patient was administered the board and asked to 
complete the questionnaire once. 
Of these four women, two chose AC and two chose CMF. 
Three women provided feedback indicating the decision board 
had been helpful and one woman commented that she preferred 
to receive an oral explanation alone rather than a combined 
oral and visual presentation. Each patient answered at 
least six out of the eight learning questions correctly, a 
75 percent level of correctness, and again a variety of 
reasons were given for each person's choice of chemotherapy. 
This pilot test provided some evidence towards 
establishing internal consistency and content validity since 
the volunteer group's questionnaire answers remained 
consistent on the first and second presentation; and, all 
pilot subjects appeared to interpret the questions and 
information as intended. I recognize that reliability and 
validity cannot be established due to the limitations of 
using this small sample size. In a larger study over an 
extended period of time, one could attempt to test for 
stability and internal consistency. 
Procedure 
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Permission to proceed with this study was obtained from 
Dr. Hal Hirte, Chairperson of the Protocol Review Committee 
at the Hamilton Regional Cancer Centre and Dr. Peter 
McCulloch, Chairperson of the Institutional Review Board for 
the Hamilton Civic Hospitals. 
In the new patient clinic, I, the researcher, and 
clinic staff together identified potentially eligible 
participants. My original goal was to see each patient, as 
a clinic nurse, to obtain each woman's health history and, 
if time allowed, to perform a physical assessment. However, 
due to time constraints and the number of eligible clients 
present in the clinic on some Thursdays, it soon became 
evident that this was not going to be possible. As a 
result, I saw most women for the presentation of the 
decision board only. When this was the case, the history 
and physical were performed by a medical oncologist, an 
oncology resident or another nurse. All of these health 
care professionals were instructed, prior to seeing a 
patient, not to comment or release any information about the 
two chemotherapy regimens. 
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Following the history and physical, the medical 
oncologist saw the patient to give the recommendation for 
chemotherapy. Also at this time the medical oncologist 
informed the patient about this study, the use of the 
decision board, questionnaires, and the written consent 
form. A copy of the consent form is found in Appendix G. 
Every patient approached agreed to participate. Next I, 
alone, presented the decision board to each woman to explain 
the two treatment options. On approximately three occasions 
I was accompanied by a medical student or another nurse who 
sat in on the presentation but remained silent. 
It is important to note that in twenty-nine of thirty 
cases the patient was accompanied to their clinic 
appointment by one to three family members or friends. 
These individuals were encouraged to listen to the decision 
board presentation with the patient and were given the 
opportunity to ask questions. 
The decision board presentation began with the board 
empty except for the headings "Chemotherapy," "Treatment A," 
and "Treatment B." The process involved reading aloud the 
print contained on five cards and explaining two bar graphs, 
each contained on a separate card, for a total of seven 
cards. The board was designed in three sections, the first 
provided general information about chemotherapy, the second 
described each treatment schedule and the third displayed 
the incidence of the side effects, nausea, vomiting, and 
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hair loss, associated with each regimen. After a brief 
introduction to the decision board, I read each card aloud 
and placed it on the board using velcro. After all seven 
cards had been discussed and placed on the board, I 
proceeded to give some additional information about each 
regimen. These details are contained in the script and were 
thought to be relevant and important for the patient to know 
prior to making a decision. They were not included on the 
face of the decision board because of space limitations and 
my concern about the board appearing overwhelming and 
crowded with information. 
The patient, with her family or friends was invited to 
ask questions after each section. The time required to 
administer the decision board ranged from 15 to 35 minutes 
depending upon the number of questions asked. 
Each patient was told that she need not make a decision 
during this clinic visit but would be given a copy of the 
information to take home and consider. Every woman left the 
clinic with an 11" X 17" copy of the decision board as well 
as a copy of the written script. 
Every woman was given a return appointment for one or 
two weeks later. She was asked to return to the clinic with 
her decision made. In four cases return appointments were 
delayed later than two weeks. Reasons for this were a 
planned vacation for one woman, further surgery was required 
for another, and a time delay in clarifying test results for 
another woman. Also, one patient decided on no treatment 
and did not return for her next appointment. Her 
questionnaire was mailed to her home and she completed it 
and returned it promptly. 
All patients were seen in the clinic in one of eight 
very similar examining rooms. 
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Upon the patient's return visit, I was the first to see 
each woman in one of the eight examining rooms. The patient 
was asked to state her preference for chemotherapy and 
offered the opportunity to ask any questions related to her 
choice. At that time I asked each woman to complete the 
questionnaire. If the patient had brought a friend or 
family member to the clinic with her, the individual was 
asked to return to the waiting room until the patient was 
finished filling out the questionnaire. Therefore, each 
woman completed the questionnaire alone in an examining 
room. The time required to complete the questionnaire 
ranged from 10 to 25 minutes. Once the questionnaire was 
completed each woman was then seen by myself and/or the 
attending medical oncologist and the friend or family member 
was invited back into the room. The discussion that then 
took place involved reviewing test results, deciding when to 
begin chemotherapy, reviewing details of the chosen 
treatment regimen and further patient teaching around the 
chemotherapy treatment process. 
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Most women were seen in the clinic by the researcher 
before every chemotherapy treatment. Therefore, there was 
continued contact between the researcher and the study 
participants. It is the current standard practice for a 
nurse and physician to see patients in the clinic prior to 
the administration of chemotherapy. This is to assess the 
patient's physical status, to allow for questions to be 
asked and for the discussion of any problems or side effects 
from treatment. 
The participants for this study were seen during their 
regular clinic visits. The only inconvenience to them was 
the time and energy required to complete the questionnaire. 
There were no anticipated physical or psychological risks to 
the participants. 
Limitations 
Perhaps the most obvious limitation of this study was 
the lack of a control group. It is recognized that an 
experimental design would have provided evidence about the 
efficacy of the decision board; however, it is believed that 
the decision board has been established as a useful 
educational tool. Therefore, from an ethical standpoint, a 
patient should not be denied access to this method of 
presenting information. 
In addition, the use of qualitative methods of data 
collection may have provided more detailed information and 
led to a greater understanding of patient choices and 
influencing factors. 
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Another limitation of this study was the specific 
population to which the patients belonged and the treatment 
choice applied. This population of women comprises 
approximately 15 percent of all breast cancer patients; 
therefore, the results are not generalizable to all women 
with breast cancer. Also, subject recruitment took longer 
than anticipated. Due to time constraints, subject 
recruitment stopped when the sample size reached 30 
subjects; therefore, when interpreting the significance of 
any results one must consider the small sample size. 
Given the population, time constraints, and 
questionnaire design, I was unable to test for other forms 
of reliability and validity. 
Attempts were made to control the patient environment 
and procedure as much as possible. A limitation, beyond my 
control, was who the patients spoke to or sought information 
from between appointments may have swayed their decision. 
As a result, it is suspected that some women made their 
choice based upon information from sources other than the 
decision board. 
This clinic was a busy site with many health care 
professionals present at one time. Nurses, physicians, and 
rotating residents and medical students kept me busy 
ensuring that everyone was informed about this study so as 
to limit the chance and incidence of contamination. 
Data Analysis 
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Descriptive statistics were calculated for all 
questionnaire items, including measures of central tendency 
and variability. Correlations were used to further examine 
the relationships among the demographics, learning 
questions, factors affecting decision making, and quality of 
life. 
The t-test was used to compare the means of the women 
who were randomly assigned to the two different versions, as 
well as those who chose AC versus those who chose CMF. A 
multivariate analysis of variance could not be performed due 
to the small sample size and the number of variables. Scale 
totals could not be calculated as many of the inter-item 
correlations were low. 
The chi-square test was used to answer the third and 
fourth sub-questions to compare the frequencies of responses 
for the non-parametric data. The data from the two women 
who chose no treatment are analyzed and reported on as part 
of the whole sample only. They are not reported on as a 
separate treatment choice group since trends cannot be 
determined from a sample of two. 
The results of these analyses are presented in Chapter 
Four. 
CHAPTER FOUR: RESULTS 
The purpose of this study was to investigate the 
factors affecting the decision-making process for 
premenopausal women with Stage II breast cancer when given a 
choice between two chemotherapy regimens. Questionnaire 
responses from those who chose AC were compared to those who 
chose CMF. Descriptive and inferential statistics are 
presented in this chapter. 
Descriptive Statistics 
Demographic data for the participants are summarized in 
Table 1. Thirty women participated in the study. The mean 
age of participants was 45.7 years, with ages ranging from 
35 to 52 and having a median of 48 years. Twenty-four women 
were married, four had never been married and two were 
divorced. Twenty-three (77 percent) had one or more 
children. The largest proportion had one or more children 
11 to 15 years of age. In addition, 15 women said they 
would have help caring for their children some or all of the 
time while 14 answered not applicable. 
Nineteen (63 percent) were employed. Nine (30 percent) 
were professionals or senior management, 11 were skilled 
workers, five clerical and five unskilled including 
homemakers who did not claim to have any additional 
training. This classification scale was adapted from 
Employment & Immigration Canada, 1993. 
Table 1 
Demographics 
N = 30 
variable 
Age 
Marital 
Never married 
Married 
Separated 
Divorced 
Widowed 
Children 
Mean 
45.7 
A child of any age 
Under 5 years 
5 to 10 
11 to 15 
16 to 19 
20 to 24 
25 and over 
Child Care 
Median 
48.0 
Yes, all or most of the time 
Some of the time 
Work 
No, not at all 
Not applicable 
No response 
Employed 
unemployed 
Student 
Full-time homemaker 
Retired 
No response 
position 
Professional/Sr. Management 
Skilled 
Clerical 
Unskilled 
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Range 
35-52 years 
N % 
4 13 
24 80 
0 0 
2 7 
0 0 
23 77 
1 3 
6 20 
10 33 
8 27 
9 30 
7 23 
12 40 
3 10 
0 0 
14 47 
1 3 
19 63 
3 10 
1 3 
5 17 
1 3 
1 3 
9 30 
11 37 
5 17 
5 17 
(table continues) 
Income 
$0 - 10,000 
$10,000 - 30,000 
$30,000 - 50,000 
Greater than $50,000 
Not applicable 
No response 
Education 
University 
College 
High School 
Other 
Religious Faith 
Jewish 
Protestant 
Roman Catholic 
None 
Other 
Religious Involvement 
I attend services weekly (or more often) 
and I am involved with my religious 
community and functions 
I attend services weekly 
I attend services occasionally 
I do not attend religious services 
N 
1 
7 
8 
12 
1 
1 
8 
4 
10 
8 
o 
13 
12 
3 
2 
7 
2 
15 
6 
Note: All percentages may not add up to 100 due to 
rounding. 
% 
3 
23 
27 
40 
3 
3 
27 
13 
33 
27 
o 
43 
40 
10 
7 
23 
7 
50 
20 
65 
66 
When asked about family income, 40 percent indicated an 
income level of greater than $50,000, 27 percent answered 
$30,000 to $50,000, and 23 percent stated $10,000 to 
$30,000. 
Twelve (40 percent) women had completed a post-
secondary educational program with eight (27 percent) having 
attended university and four (13 percent) community college. 
A high school diploma was the highest level of education for 
33 percent while 27 percent indicated "other" meaning other 
than high school, college or university. For the eight 
women who stated other, three completed up to a Grade Eight 
or Ten level while the other five had either pursued post-
secondary programs outside of college or university or 
completed only part of a college program. 
Two questions were asked about religion, one about 
chosen faith and the other about level of involvement. 
Forty-three percent were Protestant, 40 percent were Roman 
Catholic, three (10 percent) claimed no religion, two (seven 
percent) said other and none were Jewish. Fifty percent 
stated they attended their religious services occasionally, 
23 percent said they attended services weekly and were 
involved in their religious community, 20 percent said they 
did not attend and seven percent said they attended services 
weekly. 
Correlational analyses were performed on all the 
variables to better describe the relationships among the 
data (see Tables 2 and 3). Only those correlations 
Table 2 
Correlations of Demographics and Difficulty Rating of Decision with Other Variables 
variables 
Child 5-10 
Child Care 
Income 
Age of 
Children 
Have Pain 
Friend Support 
Able to Work 
Self-conscious 
Age 
-.60** 
-.63** 
*p < .01 **p < .001 
Child 
5-10 
1. 00 
Child 
11-15 
-.62** 
-.65** -.50* 
Child 
16-19 
.54* 
Child 
25&up 
- .54* 
Child 
Care 
1. 00 
.56* 
Work 
position 
- .55* 
NOTE: Only those correlations significant at p < .01 are included. 
Difficulty 
With 
Decision 
.50* 
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Table 3 
Correlations Among Factors and Quality of Life 
Quality of 
Life Items 
Feel Distant 
Friend Support 
Acceptance 
*p < .01 
Factor Items 
Side Effects 
In General 
.49* 
Maintaining Normal 
Routine 
.57* 
-.51* 
NOTE: Only those correlations significant at p < .01 are 
included. 
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significant at p < .01 are reported on. When there was 
little variance and the distribution extreme the 
correlations were not interpreted as meaningful (Coldeway, 
1989). During data entry, the demographic variable "work 
position" was coded using a scale of one to four with 
professionals or those in senior management positions coded 
one and unskilled workers coded four. This scale is in the 
opposite direction to the scale used for the variable 
"income"; therefore, a negative correlation between work 
position and income means as the level of work position 
increased so did the level of income. Also, the factor 
table was coded using a scale of one to four with "very 
important II coded one and "not applicable" coded four. This 
scale is in the opposite direction to the scale used in the 
quality of life section of the questionnaire. Therefore, a 
negative correlation between a factor item and a quality of 
life item means the two items varied in the same direction 
on the scale, both low values or both high values. 
A few interesting findings emerged from the 
correlations. The more children aged five to fifteen years 
a woman had, the more importantly she rated age of her 
children. The more children aged sixteen to nineteen years 
a woman had, the more self-conscious she said she was about 
the way she dressed. The more difficult the decision 
process was rated the less able she was to work. These 
results are presented in Table 2. In the correlations 
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between the factors and the quality of life items it is 
observed that the more importantly "side effects in general" 
was rated the less a woman perceived she had accepted her 
illness. Also, the more importantly "maintaining your 
normal routine" was rated the more she perceived support 
from friends (see Table 3). 
Eight questions were asked to assess the subjects' 
learning and comprehension from the decision board. The 
responses ranged in level of correctness from 83 percent to 
100 percent. This is presented in Table 4. 
Within the questionnaire the women were asked if they 
found the decision board helpful. As can be seen in Table 
5, 21 (70 percent) responded that they found it very 
helpful, eight quite helpful and one somewhat helpful. No 
one found the decision board not helpful. 
Treatment choice results are presented in Table 6. 
Sixteen women (53 percent) chose AC while 12 (40 percent) 
chose CMF and two women chose not to have any chemotherapy 
treatment. 
When asked if this decision was difficult to make the 
responses were varied. Five women answered "very much," six 
said "quite a bit," seven said "somewhat," four responded "a 
little bit," and, eight said "not at all" (see Table 7). 
The participants were also asked if their decision was 
influenced by anyone and who that person was. Fifteen (50 
percent) answered a family member or friend had influenced 
Table 4 
Learning Questions 
Chemotherapy can kill cancer cells 
and normal cells in the body. 
Normal cells can recover from 
chemotherapy and grow again. 
AC and CMF offer the same chance of 
survival, they both help prevent the 
cancer from coming back. 
AC takes 4 months to finish. 
CMF means coming to the centre 12 
times for treatment. 
AC means getting chemotherapy through 
an intravenous and by taking pills. 
There is a greater chance of vomiting 
with CMF. 
There is a greater chance of losing 
my hair with AC. 
# Correct 
30 
29 
27 
25 
29 
25 
27 
29 
% 
100 
97 
90 
83 
97 
83 
90 
97 
71 
72 
Table 5 
Helpfulness of Decision Board 
Rating N % 
Very much 21 70 
Quite a bit 8 27 
Somewhat 1 3 
A little bit 0 0 
Not at all 0 0 
Table 6 
Treatment Choice 
Treatment 
AC 
CMF 
None 
N 
16 
12 
2 
53 
40 
7 
73 
74 
Table 7 
Difficulty Rating of Decision 
Rating N % 
Very much 5 17 
Quite a bit 6 20 
Somewhat 7 23 
A little bit 4 13 
Not at all 8 27 
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them. Eight women stated no one influenced them, one woman 
said another patient, and two did not respond. Four women 
chose "other" which included acquaintances, a combination of 
the above people, a family physician, and a friend who was 
an echocardiogram technician. When given the option no one 
indicated that a Cancer Centre nurse or physician had 
influenced their choice. This is presented in Table 8. 
A table of 15 factors was included in the 
questionnaire. The women were asked to indicate the level 
of importance of each factor to their treatment decision. 
Table 9 presents the frequencies of each factor by the four 
point scale for the sample as a whole as well as the AC and 
CMF groups. The whole sample and the AC group rated 
"maintaining your normal routine" as "very important" the 
most often. The CMF group rated "side effects in general" 
and "vomiting" as "very important" the most often. 
Four validation questions were asked to help qualify 
the decision and the factors stated to be most important in 
making that treatment choice. These are question numbers 25 
to 28 in the third section of the questionnaire. The 
results are presented in Table 10. When asked what they 
would choose if the chance of hair loss was the same for 
both treatments 67 percent answered AC while nine (30 
percent) said CMF and one did not respond. When asked what 
they would choose if the chance of vomiting was the same for 
both treatments 70 percent answered AC while 27 percent said 
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Table 8 
Decision Influence 
N % 
A doctor at the Cancer Centre 0 0 
A nurse at the Cancer Centre 0 0 
Another patient 1 3 
A family member or friend 15 50 
Other 4 13 
No one 8 27 
No response 2 7 
77 
Table 9 
Factor Importance by Treatment Choice 
Factor Item Whole qroup AC CMF 
Very Impt Not N/A Very Impt Not N/A Very Impt Not N/A 
Side effects 16 10 2 0 4 8 2 0 10 2 0 0 
Nausea 12 10 6 0 3 8 4 0 8 1 2 0 
vomiting 14 11 4 0 3 9 3 0 10 1 1 0 
Hair loss 11 11 7 0 3 7 6 0 6 4 1 0 
# of Needles 5 11 13 0 3 5 7 0 0 6 6 0 
# of Trips 7 11 12 0 5 8 3 0 0 3 9 0 
Family role 11 14 2 2 4 7 2 2 6 6 0 0 
Home 11 14 5 0 4 9 3 0 6 5 1 0 
Children 6 7 10 7 4 3 4 5 2 4 5 1 
Family think 4 8 15 3 2 4 8 2 2 3 6 1 
Friends think 2 5 18 4 1 3 9 2 1 1 8 2 
Exp. of friend 7 6 5 11 1 3 4 7 5 2 1 4 
Work 9 7 6 8 6 2 4 4 2 4 2 4 
Finances 6 5 12 7 3 2 6 5 1 3 6 2 
Routine 17 10 1 1 9 7 0 0 7 3 1 1 
Other 0 1 0 0 0 0 0 0 0 1 0 0 
NOTE: Those women who chose no treatment or did not respond were excluded from this 
table. 
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Table 10 
Validation Questions 
Altered 
Variable AC CMF No Response 
N % N % N % 
Hair loss 20 67 9 30 1 3 
vomiting 21 70 8 27 1 3 
Duration 6 20 23 77 1 3 
# of visits 13 43 15 50 2 7 
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CMF and one did not respond. The same was asked for 
treatment duration - what if both treatments took six months 
to finish? Twenty-three women (77 percent) answered CMF 
while six said AC and one did not respond. Lastly, the 
number of treatment visits were questioned - what if CMF 
meant only one visit every four weeks instead of two for the 
six-month period? Participant responses were 50 percent for 
CMF, 43 percent for AC and two did not respond. 
The quality of life section of the questionnaire 
included 43 items. The means and standard deviations of the 
responses are presented in Table 11. The items were rated 
according to a five-point scale in terms of how true the 
statement described how the individual had been feeling 
during the past seven days. The physical well-being items 
were rated fairly low according to the means for each item 
whereas most of the social/family and all of the functional 
well-being and relationship with doctor items were rated 
high. Items under the headings emotional well-being and 
additional concerns show a mix of low and high ratings. 
The last frequency to report on is the women who 
received version One and version Two of the decision board 
and their associated treatment choice. As can be seen in 
Table 12, of the 15 women who were presented Version One, 
six (40 percent) chose AC while eight (53 percent) chose CMF 
and one chose no treatment. Of the 15 women who were 
Table 11 
Quality of Life 
Physical Well-being: 
Lack of energy 
Nausea 
Meeting needs 
Pain 
Side effects 
Feel sick 
Time in bed 
Social/Family Well-being: 
Distant from friends 
Family support 
Friend support 
Family acceptance 
Family communication 
Close to partner 
Satisfied with sex life 
Relationship with Doctor: 
Confidence in doctor 
Doctor answers questions 
o Emotional Well-being: 
Feel sad 
Proud of coping 
Losing hope 
Feel nervous 
Worry about dying 
Functional Well-being: 
Able to work 
Work is fulfilling 
Enjoy life 
Acceptance of illness 
Sleeping well 
Enjoying leisure pursuits 
Content with quality of life 
Additional Concerns: 
Short of breath 
Self-conscious about appearance 
Arms swollen/tender 
Feel sexually attractive 
Bothered by hair loss 
Worry about family risk - cancer 
Worry about effects of stress 
Bothered by weight change 
Feel like a woman 
1. 27 
.14 
.66 
.76 
.45 
.32 
.36 
.41 
3.33 
3.37 
3.45 
.39 
3.82 
3.19 
3.79 
3.86 
1. 62 
3.17 
.14 
1. 69 
1.46 
2.86 
3.11 
3.31 
3.10 
2.43 
2.93 
2.50 
.30 
.93 
1.48 
2.03 
.43 
1.90 
2.13 
.67 
2.86 
1. 02 
.44 
.86 
.99 
.74 
.67 
.56 
.93 
1.27 
1.10 
.95 
.83 
.48 
1.23 
.49 
.44 
1.27 
1.00 
.35 
1. 00 
1. 32 
1.16 
1. 03 
.76 
.86 
1.43 
1. 05 
1.38 
.75 
1. 23 
1. 30 
1. 35 
.90 
1.58 
1.31 
1.18 
1. 36 
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Table 12 
Treatment Choice by Decision Board version 
version One 
version Two 
Treatment Choice 
N % 
6 40 
10 67 
CMF 
N % 
8 53 
4 27 
None 
N % 
1 7 
1 7 
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presented Version Two, 10 (67 percent) chose AC while four 
chose CMF and one chose no treatment. 
Inferential Statistics 
In order to answer my research questions, the t-test 
and chi-square test were used as well as various post hoc 
analyses. 
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The main research question was: What factors affected 
the decision-making process for women newly diagnosed with 
Stage II breast cancer when given the choice between two 
equally effective chemotherapy regimens? The answer to this 
was obtained from the women's responses to Question 22 and 
24 on the survey_ 
Question 24 presented a table of factors where each 
woman indicated the level of importance of each factor to 
her decision. using t-tests, five factors were found to be 
rated significantly different in importance by the women who 
chose AC and those who chose CMF (see Table 13). These were 
side effects in general, vomiting, hair loss, the number of 
treatment visits, and family role (meaning their role as a 
wife, mother, daughter, or sister). The CMF group rated 
side effects in general, vomiting, hair loss, and caring for 
their family (family role) as more important than the AC 
group. The AC group rated the number of trips to the centre 
as more important than the CMF group. Table 13 presents 
two-tailed significance. 
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Table 13 
Comparison of Variables across version and Treatments 
Variable # of Cases Mean SD t-value df 
Hair Loss 
Version One 15 1. 53 0.74 -2.54 27 .017 
version Two 14 2.21 0.70 
Child 16-19 
AC 16 0.13 0.34 2.25 26 .041 
CMF 12 0.67 0.78 
Side Effects 
in General 
AC 14 1. 86 0.66 -3.29 24 .003 
CMF 12 1.17 0.39 
Vomiting 
AC 15 2.00 0.66 -3.04 25 .006 
CMF 12 1.25 0.62 
Hair Loss 
AC 16 2.19 0.75 -2.30 25 .031 
CMF 11 1.55 0.69 
# of Trips 
AC 16 1. 88 0.72 3.94 26 .001 
CMF 12 2.75 0.45 
Family role 
AC 15 2.13 0.99 -2.13 25 .044 
CMF 12 1. 50 0.52 
Sex Life 
AC 13 3.77 0.60 -2.72 22 .018 
CMF 11 2.45 1.51 
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Post hoc analyses were used to explore this question 
further. In Table 9 a breakdown of the factor table from 
Question 24 is provided. By combining the ratings from the 
"very important" column, with the ratings from the 
"important" column I found the three overall most important 
factors for the sample as a whole, including the AC group 
and the CMF group. This is presented in Table 14. The 
three most important factors to the whole group were 
maintaining their normal routine, followed by side effects 
in general and then equal ratings among vomiting, family 
role and maintaining their home. The AC group rated 
maintaining their normal routine as most important, followed 
by the number of trips and maintaining their home, and then 
vomiting and side effects in general. The CMF group 
responded that side effects in general and family role were 
the most important followed by vomiting and maintaining 
their home, and then hair loss and maintaining their normal 
routine. 
To further investigate the meaning of the number of 
trips as an important factor, I examined where each woman 
lived in terms of distance from the Cancer Centre. I 
wondered if perhaps those who had chosen AC lived further 
away than those who had chosen CMF. This was not the case 
since I found women from both groups lived in Burlington, 
Dundas, Ancaster, Caledonia, Milton, Oakville, Acton, 
Brantford, and Hagersville. 
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Table 14 
Three Most Important Factors by Treatment Choice 
Factors 
First 
Second 
Third 
Whole Group 
Maintaining 
normal routine 
Side effects 
in general 
a. vomiting 
b. Family role 
c. Maintaining 
home 
Maintaining 
normal routine 
a. Maintaining 
home 
b. # of trips 
a. Vomiting 
b. Side effects 
in general 
a. Side effects 
in general 
b. Family role 
a. vomiting 
b. Maintaining 
normal 
routine 
a. Hair loss 
b. Maintaining 
home 
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Question 22 was open-ended and asked each woman to list 
the top three reasons for her choice. A total of 75 reasons 
were given which resulted in a mean of 2.5 reasons given per 
person. To analyze these data a list of responses was 
compiled and each response was classified into one of nine 
categories. These categories were established by me based 
upon the reasons given by the women (see Table 15). The 
categories are presented in order from the highest to lowest 
number of responses. 
The quality of life category included reasons relating 
to the physical and psychological effects of treatment as 
well as comments made about maintaining or returning to 
normal or wellness. Eighteen reasons regarding quality of 
life were given, nine from the AC group and nine from the 
CMF group. 
Time referred to overall treatment duration. All 
sixteen women who chose AC named time as a reason for their 
decision. Time as a reason for choice was not stated by 
anyone who chose CMF. 
Side effects included statements where the term "side 
effects" was used, as well as, vomiting, hair loss, nausea, 
and heart effects. Side effects in general and vomiting 
were stated six times each, once from the AC group and five 
times from the CMF group. Hair loss was given as a reason 
six times, all from women who had chosen CMF. Nausea was 
given twice, both from women who had chosen CMF. Effects on 
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Table 15 
Reasons for Choice by Treatment 
Reasons for Choice Whole Group AC CMF 
Quality of Life 18 9 9 
Time 16 16 0 
Side Effects: 
In General 6 1 5 
Vomiting 6 1 5 
Hair loss 6 0 6 
Nausea 2 0 2 
Heart Effects 1 0 1 
Family Concerns 6 2 3 
Treatment Schedule 4 2 2 
Treatment Efficacy 4 2 1 
# of Trips/Distance 3 3 0 
Work 2 2 0 
Influence of Others 1 0 1 
Total 75 
Mean of Total 2.5 
the heart was given as a reason once by a woman who had 
chosen CMF. 
Family concerns took into account reasons that 
mentioned children, husbands or parents. Six reasons were 
given related to family, two from the AC group, three from 
the CMF group and one from a woman who had chosen no 
treatment. 
Treatment schedule included comments about the number 
of treatments, intravenous starts, needle pokes and 
monitoring by health care professionals throughout 
treatment. Four reasons were given relating to treatment 
schedule, two from women who had chosen AC and two from 
women who had chosen CMF. 
88 
Treatment efficacy included statements in which one 
treatment was thought to be better than the other. Four 
reasons about efficacy were given. Two of the four reasons 
came from a woman who had chosen AC. She had sought outside 
medical opinions about chemotherapy and believed AC was 
better. One reason was given by a woman who had chosen CMF 
and the other from someone who had chosen no treatment who 
was pursuing alternative homeopathic and naturopathic 
treatments. 
Number of trips and distance included reasons referring 
to transportation and the number of trips or visits. Three 
reasons were stated within this category, all from women who 
had chosen AC. 
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Work referred to employment reasons. Two statements 
were made regarding work as a reason for their choice, both 
from women who had chosen AC. 
The influence of others referred to one woman who 
stated the opinion of her family physician was one reason 
for her choice. This person had chosen CMF. 
For the whole sample the most common reason given for 
their choice was quality of life. This was followed by time 
and then an equal number of references to side effects in 
general, vomiting, hair loss, and family concerns. The AC 
group gave time as the most popular reason followed by 
quality of life and then the number of trips. The CMF group 
stated quality of life as their most common response 
followed by hair loss and then an equal number of responses 
related to side effects in general and vomiting (see 
Table 16). 
To further investigate the importance of four factors 
in particular, hair loss, vomiting, treatment duration, and 
the number of trips, the chi-square test was used to check 
for significant differences between the number of responses 
given by the AC and the CMF groups to the validation 
questions. A significant difference was found between how 
the AC group and the CMF group answered all four questions. 
This is shown in Table 17. For example, when asked what 
they would choose when the chance of hair loss was the same 
for both treatments, 15 out of 16 women in the AC group 
Table 16 
Three Most Important Reasons by Treatment Choice 
Factors Whole Group AC 
First Quality of life Time 
Second Time Quali ty of 
Life 
Third a. Side effects # of Trips 
in general 
b. vomiting 
c. Hair loss 
d. Family concerns 
CMF 
Quality of life 
Hair loss 
a. Side effects 
in general 
b. vomiting 
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Table 17 
Validation 
Choice 
AC 
CMF 
Questions 
Hair Loss 
AC CMF 
15 1 
4 8 
"/.,2 = 12.16 
p < .002 
by Treatment 
vomiting 
AC CMF 
15 1 
5 7 
"/.,2 = 9.71 
p < .008 
Choice 
Duration 
AC CMF 
6 10 
0 12 
"/.,2 = 6.15 
P < .046 
# of Trips 
AC CMF 
13 2 
0 12 
"/.,2 = 21.03 
p < .001 
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indicated they would stay with AC while one woman would have 
changed her mind and chosen CMF. In the CMF group, eight 
remained with their original decision while four women would 
have changed their mind and chosen AC. This change accounts 
for those women who chose CMF related to less chance of hair 
loss. These results support the factors rated as important 
to the treatment decision and the reasons stated for the 
choice. 
The t-test was also used to examine the effect of the 
order of presentation of the two treatments on the decision 
board. The only variable rated significantly different 
between the women who received version One of the decision 
board and those who received version Two was hair loss (see 
Table 13). Hair loss was rated more important in terms of 
treatment choice by the women who received version One. 
Therefore, since hair loss was also a factor rated 
significantly more important by the women who chose CMF than 
those who chose AC, it must be considered a possibility that 
the position of hair loss in the side effect section on the 
decision board may have had an effect on choice. Of the 
women who received version One, eight chose CMF and six 
chose AC. 
What and how much learning occurred when the decision 
board was used to convey the information about each regimen? 
On the eight learning questions scores ranged from 83 
percent to 100 percent correctness. There were also no 
significant differences found between the responses of the 
two groups on these questions with the use of t-tests. 
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Were there significant differences in the quality of 
life experienced by women who chose one chemotherapy regimen 
or the other? Using t-tests only one quality of life item 
was found to be rated significantly different by the women 
who chose AC versus those who chose CMF. The item was "I am 
satisfied with my sex life" and was rated higher in 
agreement by the women who chose AC (see Table 13). This is 
further supported by the item "I feel close to my partner" 
which approached significance for being rated higher in 
agreement by the women who chose AC. This result may have 
occurred by chance because of the number of statistical 
tests performed. 
Were there significant demographic differences between 
the women who chose one chemotherapy regimen or the other? 
The only demographic variable found to be significantly 
different was the number of children aged 16 to 19 years 
(see Table 13). Women in the CMF group had significantly 
more children in this age category than the women who chose 
AC. This result may have also occurred by chance due to the 
number of statistical tests performed. Using chi-squares 
and t-tests no other significant differences in demographics 
were found between the women who chose AC versus those who 
chose CMF. 
Was there a significant difference between the number 
94 
of women who chose one chemotherapy regimen or the other? 
Sixteen women (53 percent) chose AC while 12 (40 percent) 
chose CMF. No significant difference was found between 
these frequencies. There were also no significant 
differences found, using the chi-square test, between the 
number of women who chose AC or CMF related to whether they 
had been presented Version One or Version Two of the 
decision board. However, there may be a trend towards the 
first option as more women chose the first treatment 
presented to them (see Table 12) . 
Summary 
In summary, the results indicate that this treatment 
decision was not one-sided for this patient sample. Some 
factors were rated significantly more important than others 
by these women with breast cancer. Both similarities and 
differences were present among the responses of the women 
who chose AC versus those who chose CMF. Chapter Five will 
include the summary discussion, implications and conclusion. 
CHAPTER FIVE: SUMMARY DISCUSSION 
IMPLICATIONS AND CONCLUSION 
This study examined the decision-making process for 
thirty women choosing chemotherapy treatment for early stage 
breast cancer. The purpose was to investigate what factors 
were important to these patients when making a choice at 
this time in their lives. There was a desire to better 
understand what factors were considered by this patient 
population when invited to participate in treatment decision 
making. Through the use of a self-directed learning 
approach, women were given the opportunity to participate in 
an educational activity about their own health care and 
ultimately the process of critical thinking. 
Factors Influencing Treatment Choice 
A comparison within and between the factors and reasons 
for treatment choice reveals considerable agreement among 
those items considered to be the three most important. Some 
common themes emerge from these findings. Although the 
items may appear in a slightly different order, among the 
rankings from the whole group, the AC group, and the CMF 
group and between the rankings of the factors and the 
reasons, there is added consistency to the results. 
There are similarities present among the rankings of 
certain factors rated as important. All the factors rated 
as the three most important for each group appear more than 
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once with the exception of the number of trips and hair 
loss. This is to say that there were some factors that were 
important to both the women who chose AC and those who chose 
CMF. 
Side effects in general, vomiting, maintaining their 
home, and maintaining their normal routine were ranked 
within the three most important factors for both groups in 
making a choice of treatment. The women who chose CMF rated 
side effects in general and vomiting as significantly more 
important than the AC group; however, it appears that both 
factors were still important to the AC group. Maintaining 
their home and maintaining their normal routine were not 
rated significantly different, in terms of importance to the 
treatment choice, by the AC and CMF groups. These factors 
were important to everyone regardless of treatment choice. 
Family role was rated as important to the whole group 
and to the CMF group which follows since this factor was 
rated significantly more important by the women who chose 
CMF versus those who chose AC. The ranking of the number of 
trips and hair loss also coincides with the statistical 
significance demonstrated. Therefore, there is consistency 
between the results from the inferential statistics and the 
post hoc analyses. 
A similar pattern is present among the reasons given by 
the women for their treatment choice. Some of the same 
reasons for treatment choice were given by the whole sample, 
the women who chose AC, and those who chose CMF. These 
include quality of life, time, side effects in general, 
vomiting, and hair loss. 
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Quality of life is perhaps the most interesting and 
revealing reason for treatment choice. It was a popular 
reason for treatment choice for both the women who chose AC 
and those who chose CMF. This finding is very curious since 
the differences between the two chemotherapy regimens 
revolve around quality of life issues such as the treatment 
schedule and side effects. These results support the fact 
that quality of life is very subjective and can only be 
defined by the individual based upon what she believes 
matters most. It is evident that there were various 
perspectives among the women about the meaning of the 
different characteristics of the chemotherapy regimens. 
Time as a reason for treatment choice sparked some 
interesting comments from the women. All the women who 
chose AC gave time as a reason and all the women who chose 
CMF did not. Initially, one would assume this is logical 
for who would choose a longer treatment regimen because of 
time; however, a few women stated they considered choosing 
CMF with time as a reason because they were tempted to think 
six months of treatment might be better than two months in 
preventing disease recurrence. 
Hair loss, side effects in general, and vomiting were 
reasons given almost exclusively by women who chose CMF. 
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Therefore, the ranking of these three reasons as the third 
most common response by the whole group is accounted for by 
the number of women who chose CMF and gave hair loss, side 
effects in general and vomiting as reasons. 
Women from both treatment groups gave reasons related 
to concerns about family as reason for treatment choice; 
however, it was not one of the three most popular responses 
for either the AC or CMF group. 
Upon comparison, agreement is also evident between the 
factors considered most important related to treatment 
choice and the reasons given most often for treatment 
choice. The terms "quality of life" and "time" were not 
listed in the factor table and therefore are not 
specifically presented as important factors in the results. 
This investigator felt that as single factors both 
represented concepts that were too broad for the responses 
to be informative. However, a connection between quality of 
life and time exists with several of the factors. 
The quality of life category, created from the reasons 
stated by the women, accounts for the responses related to 
maintaining their normal routine and maintaining their home. 
Both of these as factors can be argued to be quality of life 
issues. Several of the reasons given by the women, 
regarding quality of life, referred to feeling well during 
treatment in order to keep up with what they would normally 
be doing. Examples of quality of life reasons given were 
"I want to be able to get back on track" and "It is right 
for me and my lifestyle." 
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Also, the quality of life category may have accounted 
for the strength of importance of the side effects as 
factors. Although side effects in general, vomiting, and 
hair loss were clearly present as important factors and 
reasons, they appeared to be more important as factors and 
less important as reasons. Reasons that were allocated to 
the quality of life category included statements such as "I 
don't want to be ill from the treatment," "I want to feel 
good while on chemo," and III chose eMF as it seemed less 
harsh. II The women did not specifically state IIside effects" 
but they alluded to them. Therefore this may account for 
some of the difference in the ranking of these items. 
The number of trips is visible as both an important 
factor and reason for treatment choice. Perhaps there is 
some connection between time and the number of trips related 
to the overall number of treatment visits required and the 
time frame they span. If there is some connection between 
time and the number of trips, it could be that some of the 
responses for the number of trips as an important factor are 
somewhat divided between time and the number of trips as 
reasons. 
Family role as a factor and family concerns as a reason 
are connected through a common concern for spending time 
with and caring for family members and fulfilling their role 
100 
as a wife, mother, daughter, or sister. Examples of the 
reasons given by women that were grouped into this category 
are "I want to have time for my kids" and "My mother is not 
well, I have to look after her." 
It is clear that some factors and reasons for treatment 
choice were ranked important by only a few women. Factors 
common to all three groups that were rated as less important 
were what family might think, what friends might think, and 
financial concerns. Reasons given by one or two women for 
their treatment choice were nausea, the effect of treatment 
AC on the heart, work, and the influence of others. 
The experience of a friend is worth noting since it was 
rated more important by the women who chose CMF than by 
those who chose AC. This makes sense because CMF is 
regarded as the "standard" chemotherapy treatment for 
premenopausal women with Stage II breast cancer and is more 
commonly offered by other cancer centres than AC. It is 
also used for women with other stages of breast cancer 
unlike AC. Therefore, there are many more former breast 
cancer patients who have had CMF chemotherapy than AC for 
current patients to be in contact with. 
In summary, it appears that for many women the bottom 
line of their treatment decision was the time factor versus 
the side effect factor. Those who chose AC were willing to 
take their chances on experiencing the side effects for the 
sake of being finished treatment in less than half the time 
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it would take for eMF. Those who chose CMF were less 
concerned about time and more concerned about the risk of 
side effects. Both groups expressed quality of life as an 
important factor related to their chemotherapy choice. 
Self-Directed Learning and The Decision Board 
According to the work of Knowles (1975, 1980, 1984, 
1989, 1990) and Candy (1991) the self-directed learning 
process was evident throughout this study in several ways. 
In reviewing the basic assumptions of andragogy, it can 
be seen how these assumptions were followed during this 
learning experience. The women recognized their need to 
know more information about chemotherapy for breast cancer. 
They came to the consultation seeking more information about 
cancer treatment with some degree of readiness to learn. 
The women were treated as independent and responsible 
individuals with regards to their own health care. They 
were invited to participate in the decision board 
presentation and informed from the start that they would 
have the opportunity to participate in choosing their own 
treatment. A supportive learning environment was 
established that emphasized respect for the individual. The 
learner's experience contributed to the interaction during 
the decision board presentation since most women openly 
discussed their prior knowledge of chemotherapy, the 
experience of other cancer patients they knew, their 
employment or training, and their family situation. 
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The decision board was an interactive learning activity 
that followed an organized sequence. The practical 
application of the information was clear. The women, and 
their family and friends accompanying them, had the 
opportunity to ask questions to ensure personal learning 
needs were being met. This investigator acted as an 
educator and resource person in providing information and 
facilitating the decision-making process. The women as 
learners were mutually involved in planning their treatment. 
It is important to note that several women came to 
their consultation keeping in mind traditional ideals about 
medical practice and education. This is understandable as 
the diagnosis of a life-threatening illness was unfamiliar 
territory for these women. This supports Knowles' (1990) 
point that not all learners are automatically self-directed 
and that the ability for this kind of learning needs to be 
fostered. It is questionable though whether all women 
preferred to be or had a deep psychological need to be self-
directed. 
Personal autonomy and autodidaxy, two components of 
self-directed learning as defined by Candy (1991), were also 
present during the decision board experience. 
The women in this study exercised their personal 
autonomy to varying degrees. Personal autonomy was apparent 
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as the women demonstrated their freedom of choice and their 
independence and followed through with their chosen plan. 
For some women, their treatment choice was independent of 
the influence of others. For other women, they consulted 
other people to provide them with assistance. Some sought 
out further sources of information about chemotherapy as 
well as alternative treatments. The awareness of the need 
to interact with others to assist the decision-making 
process is considered autonomous thinking as much as 
independent decision making. All women were able to make a 
choice and proceeded to put that choice into action. 
As Candy (1991) notes, autonomy is not simply a 
personal characteristic. It involves the interaction 
between the individual and the situation. Therefore, a 
person can be autonomous in some situations and not others. 
Situational variability helps to account for the varying 
level of difficulty experienced by the women in making a 
decision. At first, three women were resistant to the 
responsibility they were being given under these serious 
circumstances. They were surprised about the opportunity to 
participate in their treatment decision and had expected to 
be told what to do. One woman in particular expressed the 
most difficulty with her treatment decision and spoke of 
being unfamiliar with this kind of situation, participation 
in treatment decisions. The other women in the sample 
appeared to accept the active role in choosing their 
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treatment fairly readily yet proceeded to report varying 
levels of difficulty with the decision-making process. 
Therefore, the desire for active participation in treatment 
decision making does not necessarily indicate that the 
decision-making process will be simple. In addition, it can 
be argued that deciding not to choose is still exercising 
personal choice and autonomous thinking. However, since 
this was the first experience I had with these women I have 
no knowledge of their level of personal autonomy in other 
situations. 
The cancer centre consultation, as all health care 
consultations are, is an autodidactic opportunity for it is 
a learning experience that takes place outside of a formal 
educational setting. It is interesting that the majority of 
patients do not recognize health care education, at a clinic 
appointment or during a hospital stay, as a learning 
experience. This supports Candy's (1991) point that most 
people seldom recognize autodidactic situations as learning 
experiences and educational opportunities. 
Following autodidaxy, the decision board experience was 
learner-centred. Initiative and purpose were demonstrated 
as the women came to the consultation seeking information, 
then left having been given the information, perhaps sought 
out other resources, and returned with a decision made. 
This learning experience was life-centred for these 
women. The decision board and decision-making experience 
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promoted the transition from dependency towards self-
directed learning, with regards to both health care and 
education. This decision experience encouraged women to 
look within themselves, examine their own basic assumptions, 
and open their mind to possible treatment for a life-
threatening illness, something they probably never dreamed 
they would have to face in the near future. 
Treatment Decision Making and The Critical Thinking Process 
The treatment decision-making process seen in this 
study follows Brookfield's model of critical thinking. 
In this case the diagnosis of breast cancer was the 
trigger event. For these women the trigger was a negative 
event that was likely unexpected. The diagnosis of a life-
threatening illness can cause great upset, shock, and 
disbelief, particularly for someone who has had good health. 
The extent of the impact likely varied according to the 
individual and her personal situation. Since the women in 
this study were not seen until later in the process, I am 
unable to comment further on their immediate reactions. 
Following diagnosis, appraisal (self-examination) was 
the time taken by each woman to assess the meaning of this 
event for her and to decide how she wanted to cope with her 
cancer diagnosis. At this point each woman was clarifying 
her concerns and identifying what her goals were: for 
example, to fight the disease, to regain health, and to 
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maintain life. While trying to sort this out she may have 
experienced feelings of grief, anger, depression, and 
confusion and raised questions such as "Why is this 
happening to me?" She may also have sought out others who 
have or have had breast cancer in an attempt to identify 
with someone else in a similar situation. (The Canadian 
Cancer Society offers a volunteer visitor program for women 
with breast cancer called Reach to Recovery. Most women are 
referred to this program, soon after their diagnosis, by a 
health care professional.) The appraisal phase may have 
involved coping with decisions regarding surgical treatment 
and the start of considering future treatment such as 
radiation and chemotherapy. This phase began prior to their 
consultation appointment at the cancer centre. The 
realization of the meaning of this cancer diagnosis led each 
woman to the next phase. 
The exploration phase included a search for ways to 
cope with this diagnosis such as investigating treatment 
alternatives. At this point women came for their 
consultation at the cancer centre in search of an expert 
opinion and treatment recommendation about the possible 
benefit of additional treatment following surgery. Often 
they came looking for an explanation or information to help 
them to make sense out of this situation. They were offered 
information and the opportunity to participate in their 
treatment decision. They were given the opportunity to 
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choose from two equally effective chemotherapy regimens 
based upon their ideals, beliefs and concerns. For some 
women this may have been a new approach to health care 
delivery that they had not been exposed to previously. 
Other aspects of the exploration phase may have included 
searching for other ways of coping with the social, family, 
and emotional components of a cancer diagnosis. 
Alternative perspectives were developed following the 
consultation and decision board presentation. Each woman 
went home to think about the information, her options and 
the process of taking on an active role in her own care. 
For some women, the treatment decision took longer than for 
others and some claimed it was more difficult than did 
others. However, a decision was reached when they found a 
treatment option that made sense to them, that was congruent 
with their underlying assumptions. Each woman was able to 
arrive at a decision based upon what she felt was important. 
Developing alternative perspectives often involves 
abandoning previously held beliefs. This can be very 
difficult. Probably everyone underwent a change in their 
perspective about their health from "being a healthy person" 
to "having a cancer and needing chemotherapy treatment." 
For the women in this study it was particularly distressing 
for those who had held beliefs such as "I don't believe in 
taking any medicine." "You're the experts, I don't know 
what I should do," or "I know someone who had chemotherapy 
108 
and they got very sick and then died." Surprisingly enough, 
those who did experience bothersome side effects appeared to 
have little difficulty accepting that the side effects made 
them feel worse temporarily in order to be healthier for the 
long-term. 
The integration phase included integrating new 
perspectives, beliefs, and choices into their way of life. 
The treatment schedule meant alterations in routine for 
treatment visits, travelling, monitoring for side effects, 
and for some taking prescription tablets as part of their 
chemotherapy or to control side effects. The integration of 
new assumptions for these women also affected their routines 
and relationships with others such as family, friends, and 
those at the workplace. 
Integration was also evident as some women spoke of and 
wrote on their questionnaire about the importance of 
maintaining a positive attitude for their successful 
recovery. Others commented on the psychological side 
effects of treatment and trying to mentally prepare 
themselves to focus all their will and energy on achieving a 
cancer-free outcome. 
The integration phase was easier for some women than 
others. On subsequent clinic visits some women talked about 
the disruption to their lives and wanting everything to 
return to normal as soon as possible. Others spoke of 
feeling control and satisfaction with their new schedule, 
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not that they wanted to be in this situation but that they 
were dealing with it effectively. 
The critical thinking process for the women in this 
study extends beyond their chemotherapy decision experience. 
It will likely continue for some time as they progress 
through different phases of coping, with the diagnosis of a 
life-threatening disease, and come to question and 
reevaluate their thinking, behaviour, and underlying 
assumptions. 
Decision-Making Behaviour 
A variety of decision behaviours was noted in this 
study that contributes to the work of Pierce (1993). As 
discussed in Chapter Two, Pierce identified three styles of 
decision-making behaviour from her study of women with 
breast cancer. I discovered several points of interest in 
considering my results in relation to Pierce's work. 
The easiest style to identify was the deferrer. I 
found several of the women demonstrated qualities of the 
deferrer style as Pierce described. These women commented 
on their immediate attraction to what they perceived to be 
the safest treatment option such as "I decided in the car on 
the way home" and III never even considered AC." Although 
most women stated they had no difficulty with their 
decision, two women indicated their decision had been a 
little bit and somewhat difficult. 
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The next two styles I found more difficult to identify. 
The highest number of women appeared to demonstrate the 
delayer style. However, I found I was tempted to place 
women in the delayer category when their behaviour did not 
seem to coincide with either of the other two styles. 
Overall, these women claimed to experience some conflict in 
their decision making, usually with regards to weighing the 
side effects versus the length of treatment. A few women 
referred to reading popular sources of information. Some 
appeared to follow the first difference rule but most seemed 
to consider the whole picture when choosing their treatment. 
The latter is unlike what Pierce found. These women rated 
their decision from having been a little difficult to very 
difficult. 
The women who exhibited the deliberator style appeared 
to demonstrate only one or two qualities of this style. I 
primarily identified this style in the women who had 
informed me about their information search and those who 
rated their decision as having been difficult. Of the five 
women I found displaying this style, three said they had 
searched for more information or had sought other opinions 
such as their family physician or a specialist in 
naturopathic therapies. These three women also rated their 
decision as quite or very difficult. Another woman planned 
and performed a strategic information search about 
conventional treatment and made her choice with great 
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confidence. She expressed a personal responsibility for 
making the right choice and then rated her decision as not 
difficult at all. Confidence with choice and a lack of 
difficulty with the decision is unlike what Pierce described 
for the deliberator style. With the exception of this woman 
in particular, I am uncertain about whether the issue of 
having control was important to these women. 
Overall two women, a delayer and deliberator, directly 
stated they were unfamiliar with this form of health care 
practice and were somewhat confused as to how they could 
begin to make a choice. They said they felt less than 
qualified to participate in their treatment decisions. The 
woman, whom I identified as a deliberator, saw her family 
physician to assist her with her choice and rated her 
decision as quite difficult. The other woman, whom I 
identified as a delayer, referred to popular information 
rather than professional opinion and rated her decision as 
very difficult. 
Overall, the women I saw as deliberators did not 
consistently rate their decision as having been very 
difficult; as well as, not everyone who stated their 
decision was difficult performed the elaborate information 
search Pierce described. 
Another interesting observation was that two women did 
not follow through with their treatment plan. One woman, 
whom I identified as a deliberator, stopped taking CMF after 
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one month of treatment. She had rated her decision as 
having been quite difficult and was rather reluctant at the 
time to make a choice at all. This follows the deliberator 
style as Pierce described that these individuals are often 
less satisfied with their decision and anticipate regretting 
their decision in the future. 
Another woman, whom I identified as a deferrer, changed 
her mind after one month of treatment and asked to switch 
treatments from CMF to AC. The main reason for her choosing 
CMF had been to reduce her chance of hair loss while on 
treatment. After one cycle of CMF she lost her hair. This 
woman had been attracted to CMF since there was a lesser 
chance of hair loss and as soon as that attractive feature 
was no longer present she desired the other treatment. When 
hair conservation was no longer a feature of CMF she was 
attracted to AC for the shorter treatment schedule. with 
the exception of these two, most women expressed some degree 
of confidence with their decision making and were satisfied 
with their choice. 
For all three styles of decision making the percentage 
of women who exhibited each one was similar to the 
proportions Pierce found. For example, the smallest group 
of women demonstrated the deliberator style. All three 
styles of decision-making behaviour were demonstrated by 
women from both treatment choice groups. 
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Safety and risk were considered by all women. Their 
consideration of safety was more evident through their 
treatment choice than their decision-making behaviour. 
Generally, those women who chose CMF were more averse to 
risk towards the side effects than those who chose AC. I 
was unable to establish the decision-making style of the 
delayers and deliberators based upon their consideration of 
risk. 
It is entirely possible that behaviours characteristic 
of each style may have been demonstrated by the women 
without my knowledge. This may have either added to the 
strength of my classification of their styles or changed 
some of the classifications completely. Also, as a group 
these women displayed a wide range of emotions. This was 
expected as individuals were in different phases of coping 
with their diagnosis. Perhaps the possible link between 
emotional coping and decision-making behaviour needs to be 
addressed. Pierce's work adds insight into the decision-
making process for women with breast cancer; however, there 
is a need for further research in this area. 
Implications for Theory 
Overall the findings from this study are congruent with 
the theoretical framework used. The results support the 
link between critical thinking and decision making in health 
care, particularly for breast cancer patients involved in 
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making treatment choices. However, the results also 
demonstrate that not every woman preferred to be self-
directed in her learning. This somewhat contradicts one of 
Knowles' basic assumptions which states that everyone 
prefers and has a deep psychological need to be self-
directed. This assumption has been challenged by Brookfield 
(1986) among others. Results of this study support the need 
to question the notion of universal self-directed learning. 
Perhaps especially in a difficult emotional context, self-
directed learning is not appropriate for all individuals. 
Implications for Research 
The results from this study have led to the formulation 
of more research questions. Since quality of life was a 
major factor in this treatment decision for this group of 
women, further assessment of quality of life variables would 
be useful. A plan to follow the quality of life of the 
women in this study is already in place. Also related to 
quality of life is satisfaction with choice. This would be 
an important concept to measure during and after treatment 
completion. This feedback may reveal information that women 
feel they should be aware of when making their choice. 
The assessment of learning retention from the decision 
board later on in the treatment process would be another 
area to explore. This could provide more evidence about the 
effectiveness of the decision board as an educational tool 
or the need for formal reinforcement of learning for 
patients throughout their treatment course. 
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Longitudinal research in this area with regards to both 
quality of life and learning would be helpful to answer 
these questions. 
Subject recruitment and data collection for this study 
are being extended. As more information is obtained, it 
will be important to further note the effect of order of 
presentation on treatment choice. 
Qualitative research in this area would be important. 
Analysis of interviews and discussion could reveal more 
information about the decision-making experience for 
patients offered the opportunity to participate in their 
treatment decisions. Information about what people or 
agencies are often contacted, for support, during the 
decision time as well as spouse and family reaction and 
involvement in the decision-making process would be 
beneficial knowledge. 
Future research must acknowledge the differing levels 
of participation desired by patients. Although previous 
research supported the active involvement of young females 
with breast cancer in the treatment decision-making process, 
this study provided evidence that not every woman wanted 
that responsibility. The level of difficulty with treatment 
decisions is also important to continue to measure to learn 
more about those in particular who have difficulty with 
their decision-making process. 
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Overall, the literature demonstrates that there is a 
need to further explore the factors which are important to 
breast cancer patients when involved in treatment decisions, 
particularly about chemotherapy. It would also be 
interesting to investigate the same research questions with 
other cancer patient populations. 
Implications for Practice 
The results from this study may have an impact on 
practice. Further knowledge about the decision-making 
process for women with breast cancer has provided the nurses 
and physicians of the clinic with greater insight into why 
women make the choices they do. Quality of life has been 
revealed as a primary factor related to treatment choice 
that can only be defined by the woman herself. The need to 
develop a mechanism to help facilitate the process of 
critical thinking and assist those having difficulty making 
a decision is also recognized. 
This decision board is the third of its kind as an 
instrument to encourage participation in treatment decisions 
for women with breast cancer. Hopefully this research has 
added to its merit as an educational tool for patient 
education in a busy clinic setting. The results show that 
patients can understand and learn information related to 
their health conveyed in this manner, and that they found 
the decision board helpful for decision making. 
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As an extension of this study the quality of life of 
these thirty women has been followed throughout their 
treatment and for a few months afterward. These data, which 
are still being collected, may later suggest important 
similarities and differences between the two groups, 
providing us with additional information. 
The results obtained from this study could be useful to 
all health care professionals involved in the care of women 
with breast cancer. The staff of the breast clinic at the 
Hamilton Regional Cancer Centre have continued to offer 
women with Stage II breast cancer this choice using the 
decision board and plans have been made to formally continue 
patient recruitment and data collection. 
The results from this study will be presented at a 
poster session at the 17th Annual San Antonio Breast Cancer 
Symposium in December, 1994. 
Conclusion 
There is a general movement throughout health care 
toward increased patient involvement in decision making 
regarding care. This trend follows those from the adult 
education frameworks of self-directed learning and critical 
thinking. 
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When a person is in a context where she is dealing with 
an important personal decision while under the duress of 
serious illness, what is that decision-making process like? 
This study investigated what factors were most important to 
women newly diagnosed with breast cancer when choosing 
between two equally effective chemotherapy treatments. The 
women in this study considered quality of life as a major 
factor in their decision-making process. 
In fact, the whole issue that the women were dealing 
with is one of quality of life: for example, illness versus 
health. They identified the side effects and time as 
important factors related to their decision which really are 
properties of quality of life in this situation. So how can 
we encourage autonomy, self-directed learning, and critical 
thinking in a way that also enhances quality of life? 
As self-directed learning and critical thinking promote 
personal empowerment which in turn helps to encourage 
quality of life, it can be said that quality of life is what 
adult education is all about. This study supports that 
philosophy. 
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Appendix A 
Decision Board - Version One 
Chemotherapy Treatment Choice Side-Effects 
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Appendix B 
Stage II Breast Cancer Treatment Questionnaire A 
STAGE II BREAST CANCER TREATMENT QUESTIONNAIRE A 
NAME: DATE: 
SECTION #1 
Please answer the following questions about your lifestyle. 
1. Your present age: Years 
2. Your present marital status. (Circle number) 
1 Never married 
2 Married 
3 Separated 
4 Divorced 
5 Widowed 
3. Number of children you have in each age group. (If none, write "0") 
NUMBER OF CHILDREN 
Under 5 years of age 
5 to 10 
11 to 15 
16 to 19 
20 to 24 
25 and over 
4. Will you have help during your treatment from family or friends to care for your children? 
1 Yes, all or most of the time 
2 Some of the time 
3 No, not at all 
4 Not applicable 
5. Are you presently? (Circle number) 
1 Employed 
2 Unemployed 
3 Student 
4 Full-time homemaker 
5 Retired 
6. What are you trained as or what is your job title/position? 
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7. What was your family income (before taxes) in 1992? (Circle number) 
1 0 - $10,000 
2 10,000 - 30,000 
3 30,000 - 50,000 
4 Greater than 50,000 
8. What is the highest level of education you have completed? (Circle number) 
1 University 
2 College 
3 High School 
4 Other _______ _ 
9. What is your religious faith? (Circle number) 
1 Jewish 
2 Protestant 
3 Roman Catholic 
4 None 
5 Other: 
10. Which statement best describes your religious involvement? (Circle number) 
SECTION #2 
1 I attend services weekly (or more often) and I am involved with my religious 
community and functions 
2 I attend services weekly 
3 I attend services occasionally 
4 I do not attend religious services 
Please answer the following questions about the information presented to you. It will help us to 
improve the Decision Board. 
11. Chemotherapy can kill cancer cells and normal cells in the body. 
1 Yes 
2 Unsure 
3 No 
12. Normal cells can recover from chemotherapy and grow again. 
I Yes 
2 Unsure 
3 No 
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13. Treatment A and Treatment B offer the same chance of survival, they both help prevent the 
cancer from coming back. 
1 Yes 
2 Unsure 
3 No 
14. Treatment B - AC takes 4 months to finish. 
1 Yes 
2 Unsure 
3 No 
15. Treatment A - CMF means coming to the centre 12 times for treatment. 
1 Yes 
2 Unsure 
3 No 
16. Treatment B - AC means getting chemotherapy through an intravenous and by taking pills. 
1 Yes 
2 Unsure 
3 No 
17. There is a greater chance of vomiting with Treatment A - CMF. 
1 Yes 
2 Unsure 
3 No 
18. There is a greater chance of losing my hair with Treatment B - AC. 
1 Yes 
2 Unsure 
3 No 
19. Did you find the Decision Board helpful? 
1 Very much 
2 Quite a bit 
3 Somewhat 
4 A little bit 
5 Not at all 
Comments: 
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SECTION #3 
Please answer the following questions about how you made your decision. It is important for us to 
learn what things mean the most to patients when considering chemotherapy treatment. 
20. What treatment did you choose? (Circle number) 
1 Treatment A - CMF 
2 Treatment B - AC 
3 No Treatment 
21. Was it difficult for you to make this decision? 
1 Very much 
2 Quite a bit 
3 Somewhat 
4 A little bit 
5 Not at all 
Comments: 
22. What were your 3 most important reasons for choosing the treatment you did? 
1 
2 
3 
23. Was your decision influenced by anyone? (Circle number) 
1 A doctor at the Cancer Centre 
2 A nurse at the Cancer Centre 
3 Another patient 
4 A family member or friend 
5 Other: 
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24. For the following please show the importance of each factor to your decision about 
chemotherapy treatment? 
VERY IMPORTANT NOT NOT 
IMPORTANT IMPORTANT APPLICABLE 
The side effects in general 
Nausea 
Vomiting 
Hair Loss 
The number of needle pokes for bloodwork & 
treatment 
The number of trips to the Cancer Centre 
Caring for your family (Your role as a wife, 
mother, daughter, sister) 
Maintaining your home (Your responsibilities 
alone or as part of a family-ego housework, 
meals, gardening) 
The age of your children 
What your family might think 
What your friends might think 
The experience of a friend 
Returning to work 
Financial concerns (Loss of income, child 
care, travel expenses) 
Maintaining your normal routine 
Other 
25. What would you choose if the chance of hair loss was the same for both treatments? 
I Treatment A - CMF 
2 Treatment B - AC 
26. What would you choose if the chance of vomiting was the same for both treatments? 
I Treatment A - CMF 
2 Treatment B - AC 
27. What would you choose if both treatments took 6 months to finish? 
1 Treatment A - CMF 
2 Treatment B - AC 
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28. What would you choose if Treatment A - CMF meant 1 visit every 4 weeks (instead of 2 
visits) to the cancer centre for 6 months? 
SECI10N #4 
I Treatment A - CMF 
2 Treatment B - AC 
Below Is a list of statements that other people with your Illness have said are Important. 
By filling In one circle per line, please Indicate how true each statement has ~n for you 
during the past 7 days. 
During the past 7 days: not at a little some- quite a very 
PHYSICAL WEll-BEING all bit what bit· much 
1. I have a lack of energy ............................... _ .... _....................... @ <D Q) @ @) 
2. I have nausea....................................................... .................. @ <D Q) @ @) 
3. I have trouble meeting the needs of my family.......... .... ......... @ <D Q) @ @) 
4. I have pain............................................................................. @ <D Q) @ @) 
5. I am bothered by side effects of treatment............................. @ <D Q) @ @) 
6. In general, I feel sick................................................ .............. @ <D Q) @ @) 
7. I am forced to spend time in bed........................................... @ <D Q) Q) @) 
8. How much does your PHYSICAL WELL-BEING affect your quality of life? 
Not at all @ Q) Q) Q) @) G) ® (!) ® ® @ Very much so 
During the past 7 days: not at a littJe some- quite a very 
SOCIAL/FAMilY WEll-BEING all bit what bit much 
9. I feel distant from my friends................................................. @ 
10. I get emotional support f.om my family................................ @ 
11. I get support from my friends and neighbors........................ @ 
12. My family has accepted my illness........................................ @ 
13. Family communication about my illness is poor.................... @ 
If you have a spouse/partner, or are sexually active, 
please answer # 14-15. OtherwiS€, go to # 16. 
<D 
<D 
Q) 
<D 
Q) 
14. I feel close to my partner (or main support)............ .............. @ <D (2) Q) @) 
15. I am satisfied with my sex life............................................... @ Q) (2) @ @) 
16. How much does your SOCIAl/FAMILY WELL-BEING affect your quality of life? 
Not at a" @ Q) (2) Q) @) (2) ® (!) ® ® @ Very much so 
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During the past 7 days: not at a little some- quite a very 
RELATIONSHIP WITH DOCTOR all bit what bit much 
17. I have confidence in my doctores)...... ................................... @ <D Q) Q) @) 
18. My doctor is available to aosvver my questions..... ................ @ <D Q) Q) @) 
19. How much does your RELATIONSHIP WITH THE DOCTOR affect your quality of life? 
Not at all @ <D <.V Q) @ @ ® (J) ® ® ® Very much sa 
During the past 7 days: not at a little some- quite a very 
EMOTIONAL WELL-BEINC all bit what bit much 
20. I feel sad....................................... ....................... ................. @ <D <.V Q) @) 
21. I am proud of how I'm coping with my illness...................... @ <D <.V Q) @ 
22. I am losing hope in the fight against my illness.............. ....... @ <D Q) Q) @) 
23. I feel nervous........................................................................ @ <D Q) Q) @) 
24. I worry about dying................ .............................................. @,. . <D Q) Q) @ 
25. How much does your EMOTIONAL WELL-BEING affect your quality of life? 
Not at all @ <D <.V Q) @ @ ® (J) ® ® @ Very much so 
During the past 7 days: not at a little some- quite a very 
FUNCTIONAL WELl-BEINC all bit what bit much 
26. I am able to work (include work in home)............................. @ 
27. My work (include work in home) is fulfilling.......................... @ 
28'.1 am able to enjoy life "in the moment".... ............................. @ 
29. I have accepted my illness..................................................... @ 
30. I am sleeping well.............................................................. ... @ 
31. I am enjoying my usual leisure pursuits ................................. @ 
32. I am content with the quality of my life right now.. .............. @ 
<D 
<D 
<D 
<D 
<D 
<D 
<D 
33. How much does your FUNCTIONAL WELL-BEING affect your quality of life? 
Not at all ® <D <.V Q) @ @ ® (J) ® ® @ Very much so 
During the past 7 days: not at a little some· quite a very 
ADDITIONAL CONCERNS all bit what bit much 
34. I have been short of breath....... ........ ........ ............................ ® 
35. I am self-conscious about the way I dress ................ .. ~. . .. . . . .... @ 
36. My arms are swollen or tender........... ...... .... ......................... ® 
37.1 feel sexually attractive....... ...... ............... .... ......................... @ 
38. I have been bothered by hair loss. ... .. ... . ............. .. .... ....... ...... @ 
<D 
<D 
<D 
<D 
<D 
39. I worry about the risk of cancer in other family members. .... @ <D 
40. I worry about the effect of stress on my illness................ ...... ® <D 
41. I am bothered by a change in weight.. .. ... ........................... . @ <D 
42. I am able to feel like a woman....... ...... .................... ... ....... ... @ <D 
43. How much do these ADDITIONAL CONCERNS affect your quality of life? 
Not at all @ <D Q) Q) @ @ ® (J) ® ® @ Very much so 
@) 
@) 
@) 
@) 
@ 
@) 
@) 
@) 
@) 
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CHEMOTHERAPY INFORMATION FOR WOMEN WITH STAGE II BREAST CANCER 
DECISION BOARD SCRIPT A 
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Dr. __________ has recommended chemotherapy treatment to you. Chemotherapy 
is the word for a large group of cancer-fighting drugs. This means that there are many different drugs 
that are called chemotherapy. These drugs are used to treat different forms of cancer in the body. The 
chemotherapy I am going to tell you about is used to treat this stage of breast cancer. 
Chemotherapy kills cancer cells. It circulates throughout your body in the bloodstream. Along 
with cancer cells chemotherapy sometimes kills normal cells such as blood cells, the cells lining your 
mouth and digestive tract and hair cells. This can cause low blood counts, feeling tired, the risk of 
infection, mouth sores, diarrhea, and hair loss. The normal cells will grow back. Because of the risk 
of low blood counts, before each chemotherapy treatment every patient goes to the lab for a blood test 
and is seen by a nurse and/or doctor in the clinic. 
Chemotherapy improves your chance of survival. It reduces the risk of the cancer coming back. 
However, even with chemotherapy there is a chance the cancer may return at some point. 
Here at this centre, we offer two different chemotherapies to treat women, like yourself, who 
have had surgery for breast cancer (where the cancer was found both in your breast and under your arm 
in the lymph nodes). Both chemotherapies have the same effect, that is one is not better than the other. 
They both work to prevent the cancer from coming back. 
Let's start with Treatment A (CMF). This treatment takes about 6 months to finish. 
Treatment A (eMF) is made up of 3 drugs, 2 of the drugs are given through an intravenous (IV) in your 
arm and 1 is a pill that you take by mouth. This treatment means 2 visits per month to the Cancer 
Centre to get the IV drugs. Once the drugs are prepared it takes about 20 minutes for a nurse to give 
the IV drugs. The pills you take for 2 weeks of each month. You will take the pills once a day, every 
day during the 2 weeks. This treatment means 12 trips to the Cancer Centre. 
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Treatment A (CMF) is made up of 6 cycles, each one lasting 4 weeks. This is how the schedule 
for a cycle works. On the first day you will come to the Centre and receive the 2 drugs through an IV. 
On that same day you will be given a prescription for the pills. You will start taking the pills the next 
day. One week from the first day you will come to the Centre again to receive the 2 drugs through an 
IV. At that time you will still have one week left of taking your pills. After this day you will return 
to the clinic in 3 weeks. When you finish your pills, at home, you will have 2 weeks of no 
chemotherapy. The cycle then repeats itself. 
The side effects you may have with Treatment A (CMF) are: 
1. Nausea (upset stomach) - There is a 45% chance this may happen. This is usually mild and may last 
for only a day or two, or most of the 2 weeks when you are taking the pills. You will be given 
a prescription for some medication to help this. 
2. Vomiting (throwing up) - There is a 40% chance this may happen within the first 1 to 2 days after 
the IV chemo. You will be given a prescription for some medication to help prevent this. 
3. Hair loss - There is a 40% chance you will lose half your hair or more. More often this is seen as 
thinning of the hair. It will grow back when you are finished chemotherapy. 
Now let's talk about Treatment B (AC). This treatment takes about 2 112 months to finish. 
Treatment B (AC) is made up of 2 drugs, both are given through an intravenous (IV) in your arm. This 
treatment means 1 visit every 3 weeks to the Cancer Centre to receive the IV drugs. Once the drugs 
are prepared it takes about 60 minutes for a nurse to give the IV drugs. This treatment means 4 trips 
to the Cancer Centre. 
Treatment B (AC) is made up of 4 cycles, each one lasting 3 weeks. Each cycle is 1 treatment 
of the IV drugs. On the first day of your treatment you will come to the Centre and receive the 2 drugs 
through an IV. Three weeks from this day you will return to the Centre for another treatment. This 
cycle repeats itself for a total of 4 IV treatments. 
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The side effects you may have with Treatment B (AC) are: 
1. Nausea (upset stomach) - There is a 15% chance this may happen within a few days after chemo. 
You will be given a prescription for some medication to help this. 
2. Vomiting (throwing up) - There is a 75% chance this may happen within the first I to 2 days after 
chemo. You will be given a prescription for some medication to help prevent this. 
3. Hair loss - There is a 90% chance you will lose half your hair or more. It will grow back when you 
are finished chemotherapy. I can give you some information if you are interested in a wig. 
These are the most common side effects of these 2 chemotherapies; however, there are others 
that are less common that we have not discussed. 
Treatment A (CMF) can also cause irritated or watery eyes. 
Both Treatment A (CMF) and Treatment B CAC) can cause bladder irritation such as burning 
on urination. Drinking lots of fluids after treatment will help prevent this. 
After each treatment of Treatment B CAC) your urine may be red in colour because of the colour 
of one of the drugs . This is normal and will disappear after you have urinated a few times. 
There is also a small risk of heart damage with certain doses of Treatment B (AC). When this 
drug has been used for a long period of time heart damage has occurred in a small number of patients. 
The total dose you will be given is well within the safe accepted range. As well, all the drug doses you 
will be given will be calculated based upon your own height and weight. 
Lastly, both chemotherapies can cause changes in your menstrual cycle. The length of your 
cycle may change and you may even stop having your period. This may be temporary while you are 
on chemotherapy or it may be permanent. 
If you have any questions between now and the time you return you may call me. 
Ellen Irwin RN 387-9495 x-4409 
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Correlations of Factors 
-- -
_ ._-
Factors Side Nausea Vomiting Hair #I of #I of Family Horne Age of Family Friends Exp. Work Finances Routine Other 
Effects Loss Needles Trips Role Children Think Think of 
Friend 
Side 1. 00 
Effects 
Nausea .61** 1. 00 
Vomiting .79** .85** 1. 00 
Hair .65** .72** .69** 1. 00 
Loss 
#I of .05 .16 .10 .15 1. 00 
Needles 
#I of - .18 - .11 ·.20 .03 .54- 1. 00 
Trips 
Family .06 -.05 .03 -.09 -.39 -.48- 1. 00 
Role 
Home - .04 -.08 .00 -.06 -.28 -.37 .75** 1. 00 
Age of .05 - .14 .03 - .19 -.21 -.20 .51- .30 1. 00 
Children 
Family -.03 -.04 -.03 .11 -.01 .06 .39 .41 1. 00 
Think .47-
Friends -.05 .18 .01 .13 .13 .23 .19 .26 .10 .76** 1. 00 
Think 
Exp. of .31 .23 .32 .28 . 02 - .12 .41 .19 .33 .3 6 1. 00 
Friend .49-
Work - .10 -.04 - . 05 .02 .42 .21 -.29 -.06 ·.29 .02 -.04 .36 1. 00 
Finances . 05 .07 .03 .06 .18 .15 ·.08 - .14 -.18 ·.01 .10 .32 .63** 1. 00 
Routine -.30 -.05 - .14 ·.02 .03 -.07 .20 .18 .28 .18 .01 .3 2 . 41 .34 1. 00 
Other -- -- - - -- .. - - -- _. - - -- - . -- - - - - - - 1. 00 
* p < _01 ** p < _001 
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Correlations of Quality of Life 
01 02 03 04 05 06 07 09 010 011 012 013 014 015 017 018 020 021 
01 1.00 
02 .24 1. 00 
03 .38 .22 1.00 
04 .17 .60** .55* 1.00 
05 .14 .13 .31 .58* 1.00 
06 .49* .70** .33 .49* .31 1. 00 
07 .31 .53* .42 .75** .60** .77** 1.00 
Q9 -.23 -.12 -.21 -.04 -.01 .07 .06 1. 00 
Q10 -.02 .16 .18 .20 .28 .16 .22 -.16 1. 00 
011 -.09 .11 .10 .05 .05 -.21 -.15 -.63** .43 1. 00 
012 -.11 .09 .12 .02 .24 .10 .16 -.18 .50* .59** 1. 00 
Q13 -.27 .19 .51* .58* .16 .31 .46 .47 -.07 -.33 -.11 1. 00 
014 -.38 -.04 -.51* -.09 .23 -.17 -.03 .05 .08 .10 .30 -.39 1.00 
Q15 -.17 -.06 -.60* -.33 .03 -.18 -.35 .27 -.15 -.12 .00 -.41 .53* 1. 00 
Q17 -.32 -.19 -.43 -.36 -.23 -.58* -.66** .17 .00 .02 - . 16 -.19 .13 .33 1.00 
018 -.08 -.08 -.04 -.10 -.24 -.09 -.08 -.27 .34 .04 .00 -.08 -.11 -.18 .03 1. 00 
Q20 .46 .44 .45 .39 .22 .46 .30 .11 .00 -.11 -.30 .17 -.29 -.09 -.39 -.18 1. 00 
Q21 -.23 -.40 -.35 -.23 .21 -.56* -.28 -.06 -.07 .11 .12 -.35 .44 .39 .32 -.01 -.45 1. 00 
022 -.10 .56* .05 .23 -.25 .27 .11 -.19 .21 .23 .11 .17 -.05 -.34 -.04 .13 .31 -.40 
023 .04 -.22 -.17 -.20 - .29 -.21 -.17 .18 -.ll -.37 -.48 -.05 -.22 -.10 .30 .22 .08 .08 
024 .06 .26 -.17 .03 -.32 .16 -.08 .29 .18 -.09 -.10 -.01 -.40 -.01 .15 .12 .28 -.39 
026 -.57* -.ll -.55* -.19 -.12 -.22 -.07 .35 -.07 -.13 .07 .13 .46 .35 .47 .04 -.64** .24 
027 -.28 -.37 -.39 -.24 -.07 -.35 -.18 .33 -.33 -.38 -.26 .01 -.02 .30 .57* -.06 -.51* .31 
028 -.51* -.50* -.55* -.34 -.09 -.55* -.32 .13 -.ll .04 .08 -.03 .47 .26 .35 .05 -.58* .54* 
029 -.ll -.15 -.14 -.16 -.05 -.27 -.17 -.24 -.20 .30 .49* -.06 .38 .13 -.10 .06 -.36 .54* 
030 -.15 -.30 -.18 -.46 - . 34 -.10 -.10 -.02 -.18 -.13 -.02 -.05 -.01 -.02 .ll -.05 -.45 .12 
031 -.24 -.16 -.50* -.32 -.15 -.29 -.22 .21 -.16 -.10 .16 -.20 .35 .30 .44 .00 - . 46 .45 
032 -.29 -.35 -.38 -.48* -.23 -.38 -.25 .24 -.28 -.22 .09 -.22 .54* .35 .16 .00 -.49* .37 
034 .34 .24 .27 .39 .55* .40 .46 -.06 .07 -.01 -.05 -.18 .15 .10 -.59** -.24 .53* -.ll 
035 .21 .15 .21 .11 .19 .15 .12 .31 .19 -.08 .01 -.03 -.26 .20 .15 .05 .40 -.05 
036 .10 .44 .28 .34 .13 .35 .30 .29 .19 -.26 -.16 .33 -.27 -.03 .00 .13 .44 -.08 
037 -.08 .17 -.18 -.14 .16 .04 -.01 -.28 .25 .28 .37 -.44 .29 .19 .28 .13 -.33 .30 
038 -.13 -.07 .16 .24 .49* .ll .24 .56* .20 -.34 .05 .37 .02 .13 .14 -.02 .15 .19 
039 .19 -.07 -.01 -.07 .05 .02 -.05 .25 .14 -.34 -.38 - . 07 -.25 .17 .19 .17 .20 -.13 
Q40 .08 .33 .20 .36 -.03 .13 .25 .02 .18 -.25 -.29 .19 -.18 -.02 .15 .34 .17 -.01 
Q41 .16 .62** .27 .35 -.04 .39 .21 .ll .12 - . 04 -.11 .31 -.54* -.13 .01 .12 .53* -.31 
_Q42 -.26 -.09 .15 .05 .16 -.08 .05 - .36 .42 .41 .60** -.04 .26 -.22 -.18 .28 -.52* .26 
Continued ... 
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Correlations of Quality of Life Continued 
Q22 Q23 Q24 Q26 Q27 Q28 Q29 Q30 Q31 Q32 Q34 Q35 Q36 Q37 Q38 Q39 Q40 Q41 Q42 
Q1 
Q2 
Q3 
Q4 
Q5 
Q6 
Q7 
Q9 
Q10 
Q11 
Q12 
Q13 
Q14 
Q15 
Q17 
Q18 
Q20 
Q21 
Q22 1.00 
Q23 .02 1.00 
Q24 .25 .38 1. 00 
Q26 -.14 .04 -.06 1. 00 
Q27 -.45 .39 .10 .69** 1. 00 
Q28 -.06 .03 -.29 .62** .37 1. 00 
Q29 -.19 -.25 -.43 .34 .08 .48 1.00 
Q30 -.01 .04 -.23 .32 .27 .45 .05 1.00 
Q31 -.10 .18 .04 .57* .46 . 59** .41 .20 1.00 . 
Q32 -.29 .07 -.12 .56* .42 .38 .38 .34 .50* 1. 00 
Q34 -.14 -.20 -.06 -.40 -.42 -.49* -.21 -.35 -.50* -.08 1. 00 
Q35 -.06 .21 .28 -.18 .12 -.22 -.40 -.22 .08 -.20 -.02 1. 00 
Q36 .32 .09 .15 -.31 -.19 -.29 -.37 -.26 -.15 -.44 -.05 .65** 1.00 
Q37 .06 -.18 -.23 .23 .11 .04 .03 .16 .33 .16 .02 .09 -.05 1. 00 
Q38 -.20 .16 .00 .06 .19 .10 -.15 -.31 .18 -.15 -.05 .59** .51* .02 1.00 
Q39 -.03 .20 .16 -.03 .28 .01 -.47 .08 -.19 -.10 .11 .39 .25 .04 .23 1.00 
Q40 .19 .41 .33 .04 .15 -.22 -.20 -.18 .01 .02 -.01 .28 .41 -.06 .18 .19 1. 00 
Q41 .45 .12 .43 -.27 -.14 -.40 -.25 -.38 -.19 -.55* -.12 .51* .74** -.13 .30 .24 .41 1.00 
Q42 -.12 -.10 -.22 .13 -.09 .01 .41 -.04 .00 .11 .04 -.34 -.32 .34 -.04 L".39 -.15 -.29 1.00 
*p < .01 **p < .001 
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Appendix F 
Decision Board - version Two 
Chemotherapy Treatment Choice Side-Effects 
Treatment A - AC 
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Hamilton Regional Cancer Centre 
699 CONCESSION STREET, HAMILTON, ONTARIO L8Y 5C2 • TEL: (416) 387-9495 
Centre Regional de Cancerologie de Hamilton 
CONSENT FORM 
FACTORS AFFECTING TREATMENT DECISION MAKING 
FOR WOMEN WITH BREAST CANCER 
154 
I understand that I have been asked, with the approval of my physician, to participate in a 
research study looking at the use of a Decision Board (a teaching tool) to explain the differences 
between the two chemotherapy regimens (eMF & AC) used to treat Stage II Breast Cancer in 
premenopausal women; as well as, what factors are most important to women in this situation when 
making a decision about their treatment. 
My role in this study will be to listen to the Decision Board presentation and complete some 
questionnaires. The Decision Board will be presented to me today. I will be asked to complete the 
questionnaires when I return to the Cancer Centre for other visits. I understand my questionnaires will 
be kept confidential and will be used for research purposes only. 
I agree to participate in this study and understand the information stated above. 
Signature of Participant Date 
Signature of Witness 
Signature of Investigator 
The Ontario Cancer Treatment and Research Foundation 
La Fondafion Onfarienne pour /0 recherche en canair%gie ef /e fraitemenf du cancer 

